https://curecurrent.com/trials/potential-predictive-biological-markers-of-major-depression-response-to-citalopram-therapy-in-anorexia-nervosa-119007https://curecurrent.com/trials/cerebral-neuroinflammation-during-major-depressive-episode-119008https://curecurrent.com/trials/ketamine-trial-for-the-treatment-of-depression-119009https://curecurrent.com/trials/trial-of-transcranial-direct-current-stimulation-tdcs-119010https://curecurrent.com/trials/assesment-of-vitamin-b6-level-in-patients-with-major-depressive-disorder-119011https://curecurrent.com/trials/reward-emotion-learning-and-ketamine-study-119012https://curecurrent.com/trials/tracking-response-to-antidepressants-in-advance-of-investigational-trials-119013https://curecurrent.com/trials/tracking-response-to-antidepressants-in-advance-of-investigational-trials-relapse-study-119014https://curecurrent.com/trials/development-of-online-emdr-therapy-system-and-its-comparative-testing-with-face-to-face-emdr-therapy-for-treatment-of-an-119015https://curecurrent.com/trials/repeated-intranasal-esketamine-plus-almond-therapy-in-patients-with-treatment-resistant-depression-119016https://curecurrent.com/trials/pilot-study-assessing-computerized-cognitive-behavioral-therapy-for-depression-119017https://curecurrent.com/trials/multi-domain-psychoeducation-self-management-program-for-adults-with-mdd-in-singapore-119018https://curecurrent.com/trials/taketina-in-the-treatment-of-depression-a-pilot-study-119019https://curecurrent.com/trials/effects-of-erythropoietin-on-cognition-and-neural-activity-in-mood-disorders-119020https://curecurrent.com/trials/via-family-family-based-early-intervention-versus-treatment-as-usual-119021https://curecurrent.com/trials/investigation-of-the-effects-of-repetitive-transcranial-magnetic-stimulation-on-cognition-in-depression-119022https://curecurrent.com/trials/mediterranean-diet-and-the-microbiota-gut-brain-axis-in-major-depression-119023https://curecurrent.com/trials/ai-based-multi-center-research-on-identification-classification-aided-diagnosis-of-mood-disorder-119024https://curecurrent.com/trials/peripheral-neuroimmune-mechanisms-of-hyperthermia-119025https://curecurrent.com/trials/ketamine-as-an-augmentation-strategy-for-electroconvulsive-therapy-ect-in-depression-119026https://curecurrent.com/trials/the-study-of-ammoxetine-hydrochloride-enteric-coated-tablets-in-subjects-with-depression-119027https://curecurrent.com/trials/virtual-reality-job-interview-training-in-severe-mental-illness-119028https://curecurrent.com/trials/major-depressive-disorder-early-prediction-of-non-response-to-antidepressant-therapy-via-a-mobile-digital-scale-119029https://curecurrent.com/trials/canadian-biomarker-integration-network-for-depression-can-bind-validation-study-119030https://curecurrent.com/trials/glutamate-and-opioid-mechanisms-of-antidepressant-response-to-ketamine-119031https://curecurrent.com/trials/pilot-study-of-a-brief-behavioural-activation-intervention-for-depressed-patients-in-primary-care-119032https://curecurrent.com/trials/double-blind-treatment-of-major-depressive-disorder-with-vilazodone-119033https://curecurrent.com/trials/clinical-efficacy-and-immune-effects-of-acupuncture-in-patients-with-comorbid-chronic-pain-and-major-depression-disorder-119034https://curecurrent.com/trials/depressive-symptoms-and-subjective-stress-in-the-course-of-the-menstrual-cycle-an-ambulatory-assessment-study-119035https://curecurrent.com/trials/study-of-morphological-and-perfusion-imaging-predictors-of-pejorative-outcome-in-major-depressive-disorder-119036https://curecurrent.com/trials/effectiveness-of-cognitive-behavior-therapy-for-persons-with-depression-119037https://curecurrent.com/trials/optimal-duration-of-olanzapine-add-on-therapy-in-major-depression-119038https://curecurrent.com/trials/fmri-study-of-tes-in-major-depression-119039https://curecurrent.com/trials/deep-brain-stimulation-for-treatment-resistant-depression-119040https://curecurrent.com/trials/secondary-prevention-of-depression-through-group-based-act-therapy-preceded-by-an-experimental-abm-procedure-119041https://curecurrent.com/trials/transdiagnostic-rebt-prevention-program-for-adolescents-119042https://curecurrent.com/trials/neuroimaging-studies-of-reward-processing-in-depression-119043https://curecurrent.com/trials/postpartum-video-education-119044https://curecurrent.com/trials/effects-of-electroacupuncture-with-different-frequencies-for-major-depressive-disorder-119045https://curecurrent.com/trials/the-effect-of-intradermal-acupuncture-on-gallbladder-meridian-points-on-cerebral-hemodynamics-in-relevant-brain-regions-119046https://curecurrent.com/trials/assessing-the-impact-of-electroacupuncture-on-facial-thermal-characteristics-of-major-depressive-disorder-patients-based-119047https://curecurrent.com/trials/pet-synaptogenesis-after-psilocybin-in-depression-recovery-119048https://curecurrent.com/trials/fixed-dose-intervention-trial-of-new-england-enhancing-survival-in-smi-patients-119049https://curecurrent.com/trials/open-label-brexpiprazole-fmri-trial-in-adults-with-major-depressive-disorder-and-anxiety-119050https://curecurrent.com/trials/physical-exercise-and-depressive-symptoms-in-moderately-or-severely-depressed-adults-119051https://curecurrent.com/trials/home-administered-tdcs-for-treatment-of-depression-119052https://curecurrent.com/trials/rapid-antidepressant-effects-of-leucine-119053https://curecurrent.com/trials/web-based-self-help-intervention-for-adolescents-with-acute-or-remitted-major-depressive-disorder-119054https://curecurrent.com/trials/transcranial-magnetic-stimulation-theta-burst-tms-depression-and-smoking-119055https://curecurrent.com/trials/does-nurse-semi-structured-interview-added-to-a-rtms-improve-patients-with-major-depressive-disorder-119056https://curecurrent.com/trials/electrophysiological-correlates-of-cognition-in-depression-119057https://curecurrent.com/trials/tbs-over-dlpfc-in-elderly-refractory-depression-119058https://curecurrent.com/trials/cognitive-behavioral-therapy-for-treatment-of-insomnia-in-patients-with-major-depression-119059https://curecurrent.com/trials/myasthenia-gravis-and-psyche-119060https://curecurrent.com/trials/vortioxetine-to-prevent-return-of-symptoms-in-children-with-depression-119061https://curecurrent.com/trials/the-antidepressant-advisor-study-3-fmri-study-to-predict-treatment-response-in-patients-with-depression-119062https://curecurrent.com/trials/maintenance-transcranial-magnetic-stimulation-in-major-depressive-disorder-119063https://curecurrent.com/trials/accelerated-bilateral-rtms-on-geriatric-depression-119064https://curecurrent.com/trials/near-infrared-radiation-transcranial-photobiomodulation-for-major-depressive-disorder-119065https://curecurrent.com/trials/long-term-open-label-flexible-dose-extension-study-of-vortioxetine-in-child-and-adolescent-participants-with-major-depre-119066https://curecurrent.com/trials/neurobiological-effects-of-light-on-mdd-119067https://curecurrent.com/trials/estia-computerized-intervention-targeting-cognitive-control-deficits-in-depressed-adults-119068https://curecurrent.com/trials/treatment-of-major-depression-by-rtms-on-dorsolateral-prefrontal-cortex-study-of-underlying-mechanisms-119069https://curecurrent.com/trials/a-trial-of-enhanced-versus-standard-measurement-based-care-implementation-for-depression-119070https://curecurrent.com/trials/augmented-human-intelligence-in-major-depressive-disorder-119071https://curecurrent.com/trials/mam-te-entiendo-app-based-intervention-for-reducing-depressive-symptoms-in-postpartum-women-119072https://curecurrent.com/trials/impact-of-covid-19-pandemic-on-patients-receiving-continuation-or-maintenance-electroconvulsive-therapy-119073https://curecurrent.com/trials/pharmacogenetics-informed-tricyclic-antidepressant-dosing-pita-119074https://curecurrent.com/trials/repeated-intranasal-esketamine-plus-almond-therapy-in-participants-with-treatment-resistant-depressive-disorder-3-month-119075https://curecurrent.com/trials/covid-19-and-mental-health-in-eure-119076https://curecurrent.com/trials/online-contingent-attention-training-ocat-119077https://curecurrent.com/trials/online-cognitive-control-training-for-remitted-depressed-patients-119078https://curecurrent.com/trials/personalized-escitalopram-dosing-in-patients-with-depression-119079https://curecurrent.com/trials/personalise-antidepressant-treatment-for-unipolar-depression-combining-individual-choices-risks-and-big-data-119080https://curecurrent.com/trials/three-dosing-regimens-of-dextromethorphan-dxm-reportedly-used-in-major-depressive-disorder-119081https://curecurrent.com/trials/pf-04995274-and-emotional-processing-in-treatment-resistant-depression-119082https://curecurrent.com/trials/efficacy-and-safety-of-intradermal-acupuncture-for-major-depressive-disorder-119083https://curecurrent.com/trials/pf-04995274-and-emotional-processing-in-un-medicated-depression-119084https://curecurrent.com/trials/study-of-neural-responses-induced-by-antidepressant-effects-119085https://curecurrent.com/trials/multimodal-imaging-of-ect-effects-119086https://curecurrent.com/trials/portable-transcranial-electrical-stimulation-and-internet-based-behavioral-therapy-for-major-depression-study-119087https://curecurrent.com/trials/transcranial-direct-current-stimulation-in-a-home-treatment-setting-for-major-depression-119088https://curecurrent.com/trials/predictive-effect-of-neuroinflammatory-factors-of-the-mect-in-treatment-of-senile-depression-119089https://curecurrent.com/trials/the-role-of-neuromodulation-technique-in-depression-disorder-119090https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-cariprazine-as-an-adjunctive-treatment-to-antidepressant-therapy-adt-in-patients-wit-119091https://curecurrent.com/trials/reaching-and-engaging-depressed-senior-center-clients-reds-119092https://curecurrent.com/trials/treatment-response-biomarkers-in-mdd-119093https://curecurrent.com/trials/chinese-longitudinal-and-systematic-study-of-bioplar-disorder-119094https://curecurrent.com/trials/pharmacogenomic-testing-in-major-depressive-disorder-119095https://curecurrent.com/trials/the-phosphodiesterase-3-inhibitor-cilostazol-as-an-adjunctive-to-antidepressants-in-patients-with-major-depressive-disor-119096https://curecurrent.com/trials/a-trial-of-axs-05-in-patients-with-major-depressive-disorder-119097https://curecurrent.com/trials/open-label-safety-study-of-axs-05-in-subjects-with-depression-119098https://curecurrent.com/trials/biomarkers-of-antidepressant-response-and-development-risk-of-bipolar-disorder-119099https://curecurrent.com/trials/home-based-transcranial-direct-current-stimulation-tdcs-for-major-depressive-disorders-mdd-119100https://curecurrent.com/trials/the-study-of-effectiveness-of-rtms-on-rumination-and-anhedonia-in-patients-with-major-depressive-disorder-119101https://curecurrent.com/trials/music-as-an-intervention-to-improve-hemodynamic-tolerability-of-ketamine-in-depression-119102https://curecurrent.com/trials/scaling-mental-healthcare-in-covid-19-with-voice-biomarkers-119103https://curecurrent.com/trials/reducing-the-rate-and-duration-of-re-admissions-among-patients-with-unipolar-disorder-and-bipolar-disorder-using-smartph-119104https://curecurrent.com/trials/transcranial-magnetic-stimulation-vs-theta-burst-stimulation-in-major-depressive-disorder-119105https://curecurrent.com/trials/n-acetyl-cysteine-supplementation-in-therapy-refractory-major-depressive-disorders-119106https://curecurrent.com/trials/active-reference-fluoxetine-fixed-dose-study-of-vortioxetine-in-paediatric-participants-aged-7-to-11-years-with-major-de-119107https://curecurrent.com/trials/the-objective-of-this-study-is-to-evaluate-the-efficacy-safety-and-tolerability-of-cariprazine-as-an-adjunctive-treatmen-119108https://curecurrent.com/trials/long-term-study-with-trazodone-once-a-day-119109https://curecurrent.com/trials/enhanced-measurement-based-care-effectiveness-for-depression-embed-study-119110https://curecurrent.com/trials/prediction-and-validation-of-unipolar-depression-with-psychosocial-somatic-markers-in-a-naturalistic-cohort-recruited-in-119111https://curecurrent.com/trials/cost-utility-analysis-of-maintenance-rtms-for-treatment-resistant-depression-119112https://curecurrent.com/trials/transcranial-magnetic-stimulation-in-patients-with-a-depressive-episode-rct-trial-119113https://curecurrent.com/trials/retrospective-tms-therapy-for-adults-with-mdd-119114https://curecurrent.com/trials/clinical-validation-of-a-combinatorial-pharmacogenomic-approach-in-major-depressive-disorder-119115https://curecurrent.com/trials/precision-medicine-for-the-prediction-of-treatment-prompt-response-prompt-119116https://curecurrent.com/trials/microbiotherapy-in-characterized-depressive-disorder-119117https://curecurrent.com/trials/pentoxifylline-for-treatment-of-resistant-major-depression-119118https://curecurrent.com/trials/pentoxifylline-as-an-adjunct-to-citalopram-in-adult-patients-with-major-depressive-disorder-119119https://curecurrent.com/trials/multi-factor-model-constraction-for-early-warning-and-diagnosis-of-mdd-119120https://curecurrent.com/trials/transdiagnostic-markers-of-cognitive-symptoms-in-disorders-affective-119121https://curecurrent.com/trials/mirnas-suicide-and-ketamine-plasma-exosomal-micrornas-as-novel-biomarkers-for-suicidality-and-treatment-outcome-119122https://curecurrent.com/trials/integral-remediation-for-major-depression-rehabilitaci-n-integral-para-la-depresi-n-mayor-ridem-119123https://curecurrent.com/trials/treatment-of-depression-with-connectivity-guided-robotically-delivered-rtms-119124https://curecurrent.com/trials/tf-cbt-for-long-term-ptsd-major-depressive-disorder-and-anxiety-disorders-in-victims-of-terrorism-119125https://curecurrent.com/trials/cognitive-reappraisal-in-adolescents-with-major-depression-119126https://curecurrent.com/trials/an-eeg-study-of-intravenous-ketamine-for-major-depression-disorder-119127https://curecurrent.com/trials/a-clinical-trial-of-adjunctive-and-monotherapy-prax-114-in-participants-with-major-depressive-disorder-119128https://curecurrent.com/trials/dorsomedial-prefrontal-neuromodulation-in-treatment-resistant-depression-119129https://curecurrent.com/trials/evaluation-of-theta-burst-stimulation-efficacy-safety-and-tolerability-in-major-depressive-episodes-of-bipolar-i-disorde-119130https://curecurrent.com/trials/efficacy-and-safety-of-light-therapy-in-the-treatment-of-non-seasonal-depressive-disorder-in-chinese-population-119131https://curecurrent.com/trials/efficacy-of-daylight-as-adjunctive-treatment-in-patients-with-depression-119132https://curecurrent.com/trials/assessment-of-the-impact-of-clinical-pharmacogenomics-on-real-and-potential-medication-use-in-veterans-119133https://curecurrent.com/trials/vortioxetine-in-patients-with-depression-and-early-dementia-119134https://curecurrent.com/trials/clinical-study-of-biomarkers-of-stress-resilience-role-of-elk1-and-gpr56-119135https://curecurrent.com/trials/ect-vs-esketamine-119136https://curecurrent.com/trials/safety-and-tolerability-of-single-and-multiple-ascending-doses-of-gate-101-in-normal-human-volunteers-119137https://curecurrent.com/trials/response-to-social-rejection-in-suicidal-behavior-119138https://curecurrent.com/trials/low-dose-st-john-s-wort-for-depression-119139https://curecurrent.com/trials/evaluation-of-a-website-to-improve-depression-literacy-in-adolescents-with-depression-119140https://curecurrent.com/trials/validating-reward-related-biomarkers-rtoc-119141https://curecurrent.com/trials/a-clinical-trial-of-prax-114-in-participants-with-major-depressive-disorder-119142https://curecurrent.com/trials/pulse-width-0-15ms-vs-0-30ms-in-electroconvulsive-therapy-119143https://curecurrent.com/trials/pet-and-mri-brain-imaging-of-bipolar-disorder-119144https://curecurrent.com/trials/new-clinical-applications-for-internet-based-cognitive-behavior-therapy-for-insomnia-and-depression-119145https://curecurrent.com/trials/mechanistic-evaluation-of-response-in-trd-merit-119146https://curecurrent.com/trials/smartphone-app-based-cbt-versus-online-group-cbt-randomized-non-inferiority-clinical-trial-119147https://curecurrent.com/trials/acupuncture-augmentation-for-inpatients-with-major-depression-disorder-119148https://curecurrent.com/trials/testing-the-neuroscience-of-guided-learning-in-depression-119149https://curecurrent.com/trials/using-voice-biomarkers-to-predict-the-likelihood-of-major-depressive-disorder-119150https://curecurrent.com/trials/evaluation-of-a-website-to-improve-depression-literacy-in-parents-of-adolescents-with-depression-119151https://curecurrent.com/trials/gut-feeling-understanding-the-mechanisms-underlying-the-antidepressant-properties-of-probiotics-119152https://curecurrent.com/trials/brain-based-biomarkers-in-response-to-tms-in-mdd-119153https://curecurrent.com/trials/antidepressant-trial-with-p2x7-antagonist-jnj-54175446-119154https://curecurrent.com/trials/the-efficacy-of-acupressure-therapy-on-patient-with-depression-119155https://curecurrent.com/trials/lumateperone-monotherapy-for-the-treatment-of-bipolar-depression-conducted-globally-119156https://curecurrent.com/trials/improving-access-to-the-treatment-of-anxiety-and-depression-among-young-adults-119157https://curecurrent.com/trials/placebo-controlled-trial-of-5-hydroxytryptophan-and-creatine-for-ssri-or-snri-augmentation-in-treatment-resistant-depres-119158https://curecurrent.com/trials/the-effect-of-problem-solving-therapy-and-antidepressant-therapy-on-cerebral-perfusion-and-brain-derived-neurotropic-fac-119159https://curecurrent.com/trials/resting-state-functional-connectivity-throughout-a-course-of-itbs-in-major-depression-119160https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-in-pharmaco-na-ve-patients-with-major-depression-119161https://curecurrent.com/trials/treatment-for-major-depressive-disorder-with-intermittent-theta-burst-stimulation-119162https://curecurrent.com/trials/add-on-therapy-with-edupression-com-on-therapy-resistant-depressive-patients-treated-with-nasal-esketamine-spray-119163https://curecurrent.com/trials/adolescent-mental-health-canadian-psychiatric-risk-and-outcome-study-119164https://curecurrent.com/trials/cognitive-behavioural-therapy-for-the-treatment-of-late-life-depression-119165https://curecurrent.com/trials/pre-mapping-networks-for-brain-stimulation-2-119166https://curecurrent.com/trials/memory-enhancement-by-gamma-hydroxybutyrate-vs-trazodone-in-major-depressive-disorder-119167https://curecurrent.com/trials/tracking-depression-symptoms-with-a-health-chatbot-119168https://curecurrent.com/trials/antidepressant-response-in-older-adults-with-comorbid-ptsd-and-mdd-119169https://curecurrent.com/trials/major-memory-2-a-long-term-group-cognitive-stimulation-program-119170https://curecurrent.com/trials/omega-3-fatty-acids-for-major-depressive-disorder-with-high-inflammation-a-personalized-approach-119171https://curecurrent.com/trials/improving-physical-health-in-patients-with-psychiatric-disorders-in-general-practice-sofia-119172https://curecurrent.com/trials/acupuncture-therapy-based-on-biological-specificity-of-acupoints-for-major-depressive-disorder-119173https://curecurrent.com/trials/clinical-neurocognitive-and-emotional-effects-of-psilocybin-in-depressed-patients-proof-of-concept-119174https://curecurrent.com/trials/intradermal-needle-therapy-for-major-depressive-disorder-119175https://curecurrent.com/trials/reset-psychotherapy-the-effectiveness-of-trauma-focused-therapy-in-patients-with-depression-and-childhood-trauma-119176https://curecurrent.com/trials/a-study-of-sdi-118-in-participants-in-remission-from-depression-119177https://curecurrent.com/trials/contact-developing-new-clinical-management-strategies-119178https://curecurrent.com/trials/stanford-accelerated-intelligent-neuromodulation-therapy-for-treatment-resistant-depression-ol-cohort-119179https://curecurrent.com/trials/integrated-smoking-cessation-treatment-for-smokers-with-serious-mental-illness-119180https://curecurrent.com/trials/ssipp-vs-pst-vs-wlc-119181https://curecurrent.com/trials/antidepressant-effects-of-the-glycine-receptor-antagonist-av-101-4-chlorokynurenine-in-major-depressive-disorder-119182https://curecurrent.com/trials/comparative-effectiveness-of-pharmacogenomics-for-treatment-of-depression-119183https://curecurrent.com/trials/pipamperone-citalopram-pnb01-versus-citalopram-cit-and-versus-pipamperone-pip-in-major-depressive-disorder-mdd-119184https://curecurrent.com/trials/rct-of-psychoeducational-program-of-depression-119185https://curecurrent.com/trials/extension-study-of-pimavanserin-in-subjects-with-major-depressive-disorder-and-inadequate-response-to-antidepressant-tre-119186https://curecurrent.com/trials/inhaled-nitrous-oxide-for-treatment-resistant-depression-optimizing-dosing-strategies-119187https://curecurrent.com/trials/efficacy-of-trial-based-cognitive-therapy-and-behavioral-activation-in-treatment-of-depression-119188https://curecurrent.com/trials/behavioral-activation-for-major-depression-with-and-without-mindfulness-119189https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-levomilnacipran-er-in-pediatric-patients-7-17-years-with-major-depressive-disorder-119190https://curecurrent.com/trials/home-based-tdcs-in-major-depressive-disorder-119191https://curecurrent.com/trials/mindfulness-based-cognitive-therapy-effect-on-depression-and-c-reactive-protein-levels-after-8-weeks-of-treatment-119192https://curecurrent.com/trials/online-system-for-identifying-and-addressing-teen-depression-in-primary-care-119193https://curecurrent.com/trials/effect-of-magnesium-supplementation-in-selective-serotonin-reuptake-inhibitors-treated-major-depressive-disorder-patient-119194https://curecurrent.com/trials/open-label-flexible-dose-study-of-vortioxetine-in-patients-with-depression-in-india-119195https://curecurrent.com/trials/efficacy-of-clinical-application-of-transcranial-low-intensity-focused-ultrasonic-stimulation-for-patients-with-major-de-119196https://curecurrent.com/trials/the-bio-k-study-a-single-arm-open-label-biomarker-development-clinical-trial-of-ketamine-for-non-psychotic-unipolar-majo-119197https://curecurrent.com/trials/supported-employment-in-patient-aligned-care-teams-119198https://curecurrent.com/trials/high-intensity-interval-training-in-severe-mental-illness-119199https://curecurrent.com/trials/delphi-evaluation-of-psychiatric-conditions-119200https://curecurrent.com/trials/light-therapy-on-major-depression-disorder-119201https://curecurrent.com/trials/action-tendencies-and-prognosis-in-major-depressive-disorder-119202https://curecurrent.com/trials/the-pill-project-oral-contraceptive-and-serotonergic-brain-signaling-119203https://curecurrent.com/trials/comparison-of-vortioxetine-and-desvenlafaxine-in-adult-patients-suffering-from-depression-119204https://curecurrent.com/trials/mindfulness-based-cognitive-therapy-for-depressed-iapt-non-responders-119205https://curecurrent.com/trials/intensive-psychotherapy-for-chronic-depression-119206https://curecurrent.com/trials/using-repetitive-transcranial-magnetic-stimulation-to-study-the-role-of-frontostriatal-circuit-in-major-depressive-disor-119207https://curecurrent.com/trials/neuroinflammation-affective-and-cognitive-symptoms-in-major-depression-and-psoriasis-119208https://curecurrent.com/trials/impact-of-tdcs-on-emotional-processing-in-major-depression-119209https://curecurrent.com/trials/rtms-for-depressed-teens-a-sham-controlled-trial-part-2-119210https://curecurrent.com/trials/rtms-for-depressed-teens-a-sham-controlled-trial-part-1-119211https://curecurrent.com/trials/acceptability-and-feasibility-of-an-8-week-online-mindfulness-based-cognitive-therapy-program-among-undergraduate-studen-119212https://curecurrent.com/trials/an-investigation-of-the-relationship-between-omega-3-fatty-acid-nutrition-and-mental-health-in-children-and-adolescents-119213https://curecurrent.com/trials/mommy-baby-treatment-for-perinatal-depression-119214https://curecurrent.com/trials/loneliness-and-occurrence-of-suicide-attempts-and-suicidal-ideas-119215https://curecurrent.com/trials/adjunctive-d-cycloserine-in-major-depressive-disorder-119216https://curecurrent.com/trials/cycloserine-rtms-plasticity-augmentation-in-depression-119217https://curecurrent.com/trials/effectiveness-of-the-first-french-psychoeducational-program-on-unipolar-depression-119218https://curecurrent.com/trials/blood-biomarkers-in-suicidal-behaviour-119219https://curecurrent.com/trials/to-assess-the-safety-and-tolerability-of-an-oral-aripiprazole-escitalopram-combination-therapy-in-participants-with-majo-119220https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-an-oral-aripiprazole-escitalopram-combination-therapy-in-parti-119221https://curecurrent.com/trials/effects-of-psilocybin-in-major-depressive-disorder-119222https://curecurrent.com/trials/tvns-effects-on-motivation-in-depression-119223https://curecurrent.com/trials/a-pilot-study-on-effect-of-add-on-sulforaphane-to-ssris-and-application-of-niacin-skin-flush-response-test-in-major-depr-119224https://curecurrent.com/trials/a-comparative-study-on-efficacy-and-safety-of-add-on-sulforaphane-or-rtms-to-escitalopram-for-major-depressive-disorder-119225https://curecurrent.com/trials/study-of-desvenlafaxine-in-treating-major-depressive-disorder-119226https://curecurrent.com/trials/differential-efficacy-of-supportive-and-interpretative-psychodynamic-techniques-for-dependent-and-self-critical-depressi-119227https://curecurrent.com/trials/itbs-for-adolescent-depression-an-open-label-study-evaluating-safety-and-efficacy-of-treatment-119228https://curecurrent.com/trials/research-on-the-effects-of-combined-neurostimulation-protocols-on-stress-119229https://curecurrent.com/trials/confirm-the-effectiveness-of-predictix-genetics-antidepressant-guided-treatment-in-adults-with-mdd-119230https://curecurrent.com/trials/the-neurobiological-fundaments-of-depression-and-its-relief-through-neurostimulation-treatments-119231https://curecurrent.com/trials/evaluation-of-efficacy-of-lycium-barbarum-polysaccharide-in-people-with-subthreshold-depression-119232https://curecurrent.com/trials/testing-a-precision-psychotherapy-system-for-low-income-patients-119233https://curecurrent.com/trials/vortioxetine-as-a-novel-anti-depressant-with-improvement-in-cognitive-abilities-119234https://curecurrent.com/trials/adjunctive-pimavanserin-in-subjects-with-major-depressive-disorder-and-inadequate-response-to-antidepressant-treatment-119235https://curecurrent.com/trials/can-magnetic-brain-stimulation-help-prevent-relapse-in-depression-119236https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-ansofaxine-hydrochloride-extended-release-tablets-in-the-treatment-of-maj-119237https://curecurrent.com/trials/study-of-ammoxetine-hydrochloride-enteric-coated-tablets-in-subjects-with-depression-119238https://curecurrent.com/trials/effectiveness-of-nature-walks-in-depressed-adults-119239https://curecurrent.com/trials/decentering-and-relapse-recurrence-in-mbct-for-depression-in-adults-119240https://curecurrent.com/trials/individual-mbct-vs-cbt-in-major-depression-a-pilot-study-119241https://curecurrent.com/trials/acupuncture-for-patients-with-major-depressive-disorder-119242https://curecurrent.com/trials/cognitive-behavioral-therapy-for-treatment-of-post-traumatic-stress-disorder-and-related-problems-119243https://curecurrent.com/trials/validation-of-the-thinc-it-tool-for-cognitive-dysfunction-in-major-depressive-disorder-119244https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-an-oral-aripiprazole-escitalopram-combination-therapy-in-parti-119245https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-an-oral-aripiprazole-escitalopram-combination-therapy-in-parti-119246https://curecurrent.com/trials/efficacy-of-transcranial-direct-current-stimulation-tdcs-for-the-treatment-of-major-depressive-disorder-119247https://curecurrent.com/trials/the-safety-and-efficacy-of-psilocybin-in-cancer-patients-with-major-depressive-disorder-119248https://curecurrent.com/trials/evaluation-of-a-mental-health-physician-support-program-in-nova-scotia-119249https://curecurrent.com/trials/measuring-development-of-brain-responses-to-vocal-sounds-in-babies-of-mums-with-mental-illness-119250https://curecurrent.com/trials/adjunctive-treatment-of-major-depression-utilizing-auricular-acupuncture-119251https://curecurrent.com/trials/proof-of-concept-study-evaluating-the-efficacy-and-safety-of-mij821-in-patients-with-treatment-resistant-depression-119252https://curecurrent.com/trials/treatment-of-major-depressive-disorder-in-the-uk-using-tms-therapy-119253https://curecurrent.com/trials/automatic-self-transcending-meditation-versus-treatment-as-usual-119254https://curecurrent.com/trials/infiltrations-of-onabotulinum-toxin-a-in-resistant-depression-comparison-of-two-facial-injection-sites-119255https://curecurrent.com/trials/early-intervention-for-youth-at-risk-for-bipolar-disorder-119256https://curecurrent.com/trials/the-relationship-among-changes-in-brain-network-activation-in-adult-outpatients-with-major-depressive-disorder-119257https://curecurrent.com/trials/naltrexone-for-antipsychotic-induced-weight-gain-119258https://curecurrent.com/trials/integrated-care-in-psychotic-disorders-with-severe-mental-illness-119259https://curecurrent.com/trials/assessing-symptomatic-clinical-episodes-in-depression-119260https://curecurrent.com/trials/maternal-mental-health-trial-119261https://curecurrent.com/trials/comparison-of-orcinoside-with-placebo-in-treatment-of-mdd-119262https://curecurrent.com/trials/internet-based-interventions-for-mdd-119263https://curecurrent.com/trials/connectivity-affecting-the-antidepressant-response-study-119264https://curecurrent.com/trials/covid-19-related-health-and-practices-among-dental-hygienists-119265https://curecurrent.com/trials/the-internet-therapy-for-depression-trial-119266https://curecurrent.com/trials/promote-access-to-stop-suicide-comparison-of-follow-up-services-for-youth-at-risk-for-suicide-119267https://curecurrent.com/trials/pharmacogenomics-for-antidepressant-guidance-and-education-1-page-1-ag1-119268https://curecurrent.com/trials/effects-of-nutrients-supplementation-in-antidepressant-treated-depressive-disorder-patients-119269https://curecurrent.com/trials/link-ping-university-relational-and-interpersonal-psychotherapy-project-119270https://curecurrent.com/trials/safety-and-feasibility-of-combined-trigeminal-and-occipital-transcutaneous-nerve-stimulation-cto-tns-in-major-depressive-119271https://curecurrent.com/trials/adaptive-design-study-of-nest-stms-in-subjects-with-major-depressive-disorder-119272https://curecurrent.com/trials/self-focus-in-bipolar-disorder-a-functional-magnetic-resonance-imaging-fmri-study-119273https://curecurrent.com/trials/step-away-from-depression-evaluation-of-a-pedometer-intervention-with-inpatients-with-major-depression-119274https://curecurrent.com/trials/linear-asymmetric-rtms-in-adolescent-treatment-resistant-depression-tolerability-of-treatment-durations-ranging-from-ten-119275https://curecurrent.com/trials/long-term-neurocognitive-and-psychiatric-consequences-in-severe-covid-19-survivors-119276https://curecurrent.com/trials/biomarkers-of-social-sensitivity-in-major-depression-119277https://curecurrent.com/trials/exploring-engagement-with-remote-symptom-tracking-for-depression-radar-engage-119278https://curecurrent.com/trials/simvastatin-as-an-augmentation-treatment-for-treatment-resistant-depression-randomized-controlled-trial-119279https://curecurrent.com/trials/psychotherapy-plus-combining-cognitive-behavioral-therapy-with-tdcs-119280https://curecurrent.com/trials/tolerability-and-pharmacokinetics-of-hypidone-hydrochloride-in-healthy-subjects-119281https://curecurrent.com/trials/study-evaluating-effexor-xr-in-chinese-subjects-with-major-depressive-disorder-119282https://curecurrent.com/trials/study-evaluating-desvenlafaxine-succinate-sustained-release-tablets-dvs-sr-in-the-treatment-of-child-and-adolescent-outp-119283https://curecurrent.com/trials/the-gut-microbiota-of-bipolar-and-depression-119284https://curecurrent.com/trials/mrs-and-medication-response-a-pilot-study-119285https://curecurrent.com/trials/sevoflurane-for-treatment-resistant-depression-119286https://curecurrent.com/trials/glabellar-botulinum-toxin-injections-for-the-treatment-of-geriatric-depression-119287https://curecurrent.com/trials/evaluation-of-mhealth-for-serious-mental-illness-119288https://curecurrent.com/trials/brain-mechanisms-of-human-motivation-119289https://curecurrent.com/trials/fluoxetine-and-bupropion-to-treat-patients-with-depression-and-alcoholism-119290https://curecurrent.com/trials/multimodal-mri-characteristics-of-psychotherapy-response-in-late-life-depression-119291https://curecurrent.com/trials/stimulation-of-parieto-hippocampal-connectivity-in-patients-with-major-depressive-disorder-119292https://curecurrent.com/trials/psychotherapeutic-augmentation-of-brain-stimulation-effects-119293https://curecurrent.com/trials/quality-of-life-in-chinese-working-and-school-age-population-with-mdd-119294https://curecurrent.com/trials/behavioral-activation-and-varenicline-for-smoking-cessation-in-depressed-smokers-119295https://curecurrent.com/trials/psychotherapy-and-cardiovascular-risk-factors-in-depression-119296https://curecurrent.com/trials/therapy-with-an-oxytocin-adjunct-for-major-depression-119297https://curecurrent.com/trials/brief-digital-cbt-for-mood-and-anxiety-symptoms-in-acute-psychiatric-inpatients-119298https://curecurrent.com/trials/mental-and-psychological-problems-and-insomnia-disorder-of-medical-staff-in-hospital-with-infected-covid-19-patients-119299https://curecurrent.com/trials/an-evaluation-of-axs-05-for-the-treatment-of-trd-in-treatment-adherent-patients-119300https://curecurrent.com/trials/a-phase-ii-study-of-pdc-1421-capsule-to-evaluate-the-safety-and-efficacy-in-patients-with-major-depressive-disorder-119301https://curecurrent.com/trials/sensory-and-psychomotor-profile-in-depression-119302https://curecurrent.com/trials/brain-connectivity-and-response-to-tai-chi-in-geriatric-depression-119303https://curecurrent.com/trials/a-long-term-study-of-alks-5461-in-the-treatment-of-refractory-major-depressive-disorder-mdd-119304https://curecurrent.com/trials/alpha-stim-aid-and-major-depressive-disorder-119305https://curecurrent.com/trials/interactive-voice-based-administration-of-the-phq-9-119306https://curecurrent.com/trials/investigation-of-brain-network-dynamics-in-depression-119307https://curecurrent.com/trials/comparing-engage-to-pst-for-late-life-depression-119308https://curecurrent.com/trials/continuation-with-vortioxetine-in-child-and-adolescent-patients-with-major-depressive-disorder-mdd-from-7-to-17-years-of-119309https://curecurrent.com/trials/spd489-adult-major-depressive-disorder-mdd-open-label-safety-and-tolerability-rollover-extension-study-119310https://curecurrent.com/trials/exploratory-study-of-spd489-in-adults-with-major-depressive-disorder-mdd-as-augmentation-therapy-to-an-antidepressant-119311https://curecurrent.com/trials/risperidone-and-suicidality-in-major-depressive-disorder-119312https://curecurrent.com/trials/efficacy-and-safety-study-of-spd489-in-combination-with-an-antidepressant-in-the-treatment-of-adults-with-major-depressi-119313https://curecurrent.com/trials/efficacy-and-safety-study-of-spd489-in-combination-with-an-antidepressant-in-the-treatment-of-adults-with-major-depressi-119314https://curecurrent.com/trials/dbs-of-the-habenula-for-treatment-resistant-major-depression-119315https://curecurrent.com/trials/influence-of-rtms-on-symptoms-and-cognitive-function-in-patients-with-psychiatric-disorders-119316https://curecurrent.com/trials/spd489-in-combination-with-an-antidepressant-in-the-treatment-of-adults-with-major-depressive-disorder-119317https://curecurrent.com/trials/spd489-in-adults-with-persistent-executive-function-impairments-efi-and-partial-or-full-remission-of-recurrent-major-dep-119318https://curecurrent.com/trials/the-effect-on-cognition-of-terminating-ect-induced-seizures-with-propofol-119319https://curecurrent.com/trials/depression-and-anxiety-in-long-term-coronavirus-disease-covid-19-119320https://curecurrent.com/trials/tdcs-in-pediatric-and-teenage-patients-with-major-depressive-disorder-during-covid-19-pandemic-119321https://curecurrent.com/trials/burst-suppression-anesthesia-for-treatment-of-severe-depression-119322https://curecurrent.com/trials/virtual-reality-behavioral-activation-an-intervention-for-major-depressive-disorder-119323https://curecurrent.com/trials/real-life-effectiveness-of-vortioxetine-in-depression-119324https://curecurrent.com/trials/memflex-to-prevent-depressive-relapse-119325https://curecurrent.com/trials/recovering-damaged-cells-for-sequelae-caused-by-covid-19-sars-cov-2-119326https://curecurrent.com/trials/sequential-therapy-for-the-treatment-of-severe-bipolar-depression-119327https://curecurrent.com/trials/treating-smokers-with-mental-illness-119328https://curecurrent.com/trials/internet-based-cognitive-behavioral-therapy-effects-on-depressive-cognitions-and-brain-function-119329https://curecurrent.com/trials/neuromodulation-device-use-in-patients-with-major-depressive-disorder-119330https://curecurrent.com/trials/effects-of-adding-motivational-interviewing-to-antidepressant-treatment-for-hispanic-adults-with-depression-119331https://curecurrent.com/trials/open-trial-of-duloxetine-in-outpatients-with-irritable-bowel-syndrome-symptoms-and-co-morbid-major-depression-119332https://curecurrent.com/trials/implementation-of-harmonized-depression-outcome-measures-in-a-health-system-119333https://curecurrent.com/trials/event-related-potentials-in-borderline-personality-disorder-and-major-depression-119334https://curecurrent.com/trials/implementation-of-harmonized-depression-outcome-measures-in-a-primary-care-registry-and-a-mental-health-registry-119335https://curecurrent.com/trials/transcranial-magnetic-stimulation-tms-for-motor-symptoms-in-psychiatric-disorders-119336https://curecurrent.com/trials/btrx-246040-administered-once-daily-to-patients-with-major-depressive-disorder-119337https://curecurrent.com/trials/pharmacokinetics-of-ago178-in-participants-with-liver-impairment-119338https://curecurrent.com/trials/the-safety-efficacy-and-tolerability-of-microbial-ecosystem-therapeutic-2-in-people-with-major-depression-119339https://curecurrent.com/trials/effectiveness-of-walking-exercise-in-improving-depression-in-older-adults-with-major-depressive-disorder-a-pilot-study-119340https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-cp-601-927-augmentation-of-antidepressant-therapy-in-major-depression-119341https://curecurrent.com/trials/patient-outcomes-reporting-for-timely-assessments-of-life-with-depression-portal-depression-119342https://curecurrent.com/trials/effects-of-low-dose-ketamine-as-an-adjunct-to-propofol-based-anesthesia-for-electroconvulsive-therapy-119343https://curecurrent.com/trials/probiotic-supplementation-in-severe-depression-119344https://curecurrent.com/trials/glutamate-probes-in-adolescent-depression-119345https://curecurrent.com/trials/vortioxetine-in-patients-with-depression-coexisting-with-general-anxiety-disorder-gad-119346https://curecurrent.com/trials/icbt-for-depression-a-factorial-investigation-of-kinds-of-therapist-support-and-self-expert-selected-content-119347https://curecurrent.com/trials/esketamine-adjuvant-therapy-for-patients-with-chronic-visceral-pain-comorbid-major-depressive-disorder-119348https://curecurrent.com/trials/rtms-study-in-depression-to-evaluate-the-relationship-between-brain-plasticity-and-clinical-outcome-119349https://curecurrent.com/trials/a-study-of-alks-5461-for-treatment-refractory-major-depressive-disorder-mdd-119350https://curecurrent.com/trials/augmenting-rtms-with-cognitive-control-training-in-major-depressive-disorder-119351https://curecurrent.com/trials/nitrous-oxide-for-major-depressive-disorder-119352https://curecurrent.com/trials/effect-of-a-single-nights-wake-followed-by-bright-light-therapy-for-severe-depression-119353https://curecurrent.com/trials/ketamine-iv-classic-protocol-five-years-follow-up-119354https://curecurrent.com/trials/effectiveness-of-ipt-g-in-major-depression-119355https://curecurrent.com/trials/a-phase-3-study-of-lu-aa21004-in-patients-with-major-depressive-disorder-119356https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-axs-05-in-subjects-with-treatment-resistant-major-depressive-disorder-119357https://curecurrent.com/trials/cholinergic-modulation-of-condition-and-emotion-in-mood-disorders-functional-neuroimaging-studies-119358https://curecurrent.com/trials/wake-therapy-in-the-treatment-of-depression-119359https://curecurrent.com/trials/assesment-of-retinal-nerve-fiber-layer-in-first-episode-depressive-patients-using-selective-serotonin-reuptake-inhibitor-119360https://curecurrent.com/trials/investigation-of-seasonal-variations-of-brain-structure-and-connectivity-in-sad-119361https://curecurrent.com/trials/chronobiology-sleep-related-risk-factors-and-light-therapy-in-perinatal-depression-the-life-on-project-119362https://curecurrent.com/trials/community-based-mental-health-care-for-people-with-severe-and-enduring-mental-iii-health-119363https://curecurrent.com/trials/ketamine-for-mood-disorders-with-suicidal-ideation-119364https://curecurrent.com/trials/ecologically-valid-virtual-tasks-vs-paper-pencil-methods-in-cognitive-rehabilitation-in-patients-with-schizophrenia-and-119365https://curecurrent.com/trials/mclean-and-genomind-prospective-study-119366https://curecurrent.com/trials/antidepressant-decision-aid-for-major-depressive-disorder-patients-119367https://curecurrent.com/trials/clinical-trial-on-efficacy-of-rtms-to-improve-ect-in-treatment-resistant-depression-119368https://curecurrent.com/trials/an-expert-system-to-reduce-depression-in-primary-care-119369https://curecurrent.com/trials/a-study-to-evaluate-the-benefit-of-opti-me-application-to-different-treatments-of-mdd-119370https://curecurrent.com/trials/biomarkers-of-response-to-treatment-with-frontal-cortex-stimulation-for-anxious-depression-119371https://curecurrent.com/trials/cognitive-training-program-for-individuals-with-depression-and-post-traumatic-stress-disorder-119372https://curecurrent.com/trials/fisher-wallace-neurostimulation-depression-study-119373https://curecurrent.com/trials/the-effects-of-perioperative-painting-art-therapy-lom-solution-centered-art-therapy-in-surgical-patients-119374https://curecurrent.com/trials/korean-post-marketing-surveillance-to-observe-effectiveness-and-safety-of-pristiq-119375https://curecurrent.com/trials/beat-it-behavioural-activation-and-severe-learning-disabilities-119376https://curecurrent.com/trials/lactobacillus-helveticus-in-the-treatment-of-major-depression-119377https://curecurrent.com/trials/mantra-meditation-in-major-depression-119378https://curecurrent.com/trials/can-the-memory-support-intervention-improve-depression-outcome-following-cognitive-therapy-119379https://curecurrent.com/trials/neuropsychological-factors-associated-with-vulnerability-to-suicidal-behavior-in-depressed-elderly-patients-119380https://curecurrent.com/trials/feasibility-and-acceptability-of-a-healthy-nordic-diet-intervention-in-depressed-and-non-depressed-adults-119381https://curecurrent.com/trials/antidepressant-response-in-the-treatment-of-depressive-symptoms-and-frailty-characteristics-in-older-adults-119382https://curecurrent.com/trials/lithium-versus-paroxetine-in-patients-with-major-depression-who-have-a-family-history-of-bipolar-disorder-or-suicide-119383https://curecurrent.com/trials/venlafaxine-er-phase-3-study-for-major-depressive-disorder-mdd-119384https://curecurrent.com/trials/venlafaxine-er-long-term-extension-study-for-major-depressive-disorder-mdd-119385https://curecurrent.com/trials/a-comparison-of-sertraline-reboxetine-combination-therapy-versus-sertraline-or-reboxetine-monotherapy-in-the-treatment-o-119386https://curecurrent.com/trials/effect-of-zinc-supplementation-on-depression-in-ssri-treated-major-depressive-disorder-patients-119387https://curecurrent.com/trials/a-comparison-of-sertraline-versus-venlafaxine-xr-in-the-treatment-of-major-depression-119388https://curecurrent.com/trials/meditation-for-dementia-caregivers-major-depressive-disorder-in-family-dementia-caregivers-119389https://curecurrent.com/trials/the-efficacy-and-safety-of-tdcs-in-patients-with-mild-to-moderate-major-depressive-disorder-119390https://curecurrent.com/trials/the-role-of-hnks-in-the-antidepressant-effect-of-ketamine-119391https://curecurrent.com/trials/investigating-predictors-of-treatment-response-in-treatment-resistant-depression-trd-with-interleaved-tms-fmri-119392https://curecurrent.com/trials/vortioxetine-5-10-and-20-mg-relapse-prevention-study-in-adults-with-major-depressive-disorder-mdd-119393https://curecurrent.com/trials/the-safety-and-efficacy-of-brexpiprazole-as-adjunctive-therapy-in-the-treatment-of-major-depressive-disorder-119394https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-trajectory-of-outcomes-study-119395https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-agomelatine-sublingual-tablets-in-the-treatment-of-major-depressive-disorder-mdd-119396https://curecurrent.com/trials/open-label-long-term-52-weeks-safety-and-tolerability-of-agomelatine-sublingual-tablets-in-major-depressive-disorder-mdd-119397https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-agomelatine-sublingual-tablets-in-the-treatment-of-major-depressive-disorder-119398https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-agomelatine-in-the-prevention-of-relapse-of-major-depressive-disorder-119399https://curecurrent.com/trials/brainsway-dtms-for-treatment-of-mdd-using-itbs-119400https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-agomelatine-in-the-treatment-of-major-depressive-disorder-119401https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-agomelatine-in-the-treatment-of-major-depressive-disorder-119402https://curecurrent.com/trials/a-placebo-and-paroxetine-controlled-study-of-the-efficacy-safety-and-tolerability-of-agomelatine-25-or-50-mg-in-the-trea-119403https://curecurrent.com/trials/the-role-of-sex-steroids-and-serotonin-brain-dynamics-in-perinatal-mental-health-119404https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-min-117-in-adult-patients-with-major-depressive-disorder-119405https://curecurrent.com/trials/hippocampal-volume-in-young-patients-with-major-depression-before-and-after-combined-antidepressive-therapy-119406https://curecurrent.com/trials/study-on-the-influence-of-electroconvulsive-therapy-ect-on-homocysteine-levels-119407https://curecurrent.com/trials/dexmedetomidine-adjuvant-treatment-for-depressed-patients-undergoing-ect-119408https://curecurrent.com/trials/characterize-the-regional-distribution-of-11c-abp688-in-brain-by-positron-emission-tomography-pet-119409https://curecurrent.com/trials/brexpiprazole-rexulti-safety-and-efficacy-among-filipino-patients-raise-a-post-marketing-surveillance-program-119410https://curecurrent.com/trials/nmda-modulation-in-major-depressive-disorder-in-late-life-119411https://curecurrent.com/trials/the-safety-tolerability-and-pharmacokinetics-study-of-hec113995-119412https://curecurrent.com/trials/brain-network-activation-analysis-to-diagnose-assess-treatment-of-unipolar-major-depression-and-bipolar-i-depression-119413https://curecurrent.com/trials/the-uthealth-ketamine-project-119414https://curecurrent.com/trials/mindfulness-based-cognitive-therapy-and-antidepressant-medication-in-recurrent-depression-119415https://curecurrent.com/trials/group-cbt-and-exercise-in-management-of-depression-119416https://curecurrent.com/trials/evaluation-of-the-safety-and-pharmacokinetics-of-msi-195-to-a-commercial-s-adenosylmethionine-119417https://curecurrent.com/trials/improving-mood-in-assisted-living-settings-119418https://curecurrent.com/trials/effectiveness-of-a-mobile-texting-intervention-for-people-with-serious-mental-illness-119419https://curecurrent.com/trials/the-island-study-insula-assessed-needs-for-depression-119420https://curecurrent.com/trials/biological-markers-of-treatment-response-to-repetitive-transcranial-magnetic-stimulation-for-depression-119421https://curecurrent.com/trials/wellness-monitoring-for-major-depressive-disorder-119422https://curecurrent.com/trials/long-term-follow-up-study-119423https://curecurrent.com/trials/dimensional-approach-to-evaluate-reward-processing-in-major-depressive-disorder-pre-and-post-desvenlafaxine-treatment-119424https://curecurrent.com/trials/to-explore-the-safety-and-efficacy-of-hypidone-hydrochloride-tablets-in-treatment-of-patients-with-mdd-119425https://curecurrent.com/trials/study-to-explore-the-effective-doses-and-to-assess-the-safety-and-efficacy-of-hypidone-hydrochloride-tablets-119426https://curecurrent.com/trials/evaluation-of-efficacy-of-lycium-barbarum-polysaccharide-in-patients-with-major-depressive-disorder-119427https://curecurrent.com/trials/intra-nasal-vs-intra-venous-ketamine-administration-119428https://curecurrent.com/trials/the-safety-tolerability-and-pharmacokinetics-study-of-hec113995-pa-h2o-tablets-in-healthy-subjects-119429https://curecurrent.com/trials/feasibility-of-internet-delivered-cbt-for-adolescents-with-depression-119430https://curecurrent.com/trials/study-to-treat-major-depressive-disorder-with-a-new-medication-119431https://curecurrent.com/trials/stress-systems-and-psychotherapy-in-depression-119432https://curecurrent.com/trials/tocilizumab-augmentation-in-treatment-refractory-major-depressive-disorder-119433https://curecurrent.com/trials/prevention-of-relapse-recurrence-of-bipolar-depression-119434https://curecurrent.com/trials/leveraging-eeg-for-antidepressant-prediction-with-duloxetine-and-bupropion-119435https://curecurrent.com/trials/adjunct-minocyline-in-treatment-resistant-depression-119436https://curecurrent.com/trials/a-double-blind-sham-controlled-trial-of-rtms-in-treatment-resistant-major-depression-119437https://curecurrent.com/trials/leveraging-eeg-for-antidepressant-prediction-with-sertraline-and-escitalopram-119438https://curecurrent.com/trials/cost-effectiveness-and-quality-of-life-assessment-in-major-depression-disorder-119439https://curecurrent.com/trials/tms-in-the-treatment-of-the-sequelae-of-closed-brain-injury-119440https://curecurrent.com/trials/a-double-blind-sham-controlled-trial-of-tdcs-in-treating-schizophrenia-and-depression-119441https://curecurrent.com/trials/study-of-monotherapy-rapastinel-in-the-prevention-of-relapse-in-patients-with-major-depressive-disorder-mdd-119442https://curecurrent.com/trials/indirect-evaluation-of-lithium-level-in-blood-using-non-invasive-sweat-biosensors-119443https://curecurrent.com/trials/the-modular-protocol-for-mental-health-mpmh-119444https://curecurrent.com/trials/transcranial-magnetic-stimulation-for-adolescent-depression-119445https://curecurrent.com/trials/exploring-effects-of-electroconvulsive-therapy-on-the-human-brain-in-depression-the-danish-ect-mri-study-119446https://curecurrent.com/trials/transcranial-laser-therapy-continuous-and-pulsed-light-for-major-depressive-disorder-elated-3-119447https://curecurrent.com/trials/efficacy-of-blue-light-treatment-in-patients-with-nonseasonal-major-depressive-disorder-119448https://curecurrent.com/trials/trans-diagnostic-group-cbt-vs-standard-group-cbt-for-depression-social-anxiety-and-agoraphobia-panic-disorder-119449https://curecurrent.com/trials/seasonal-affective-disorder-and-visual-impairment-119450https://curecurrent.com/trials/brain-oscillation-synchronised-stimulation-of-the-prefrontal-cortex-119451https://curecurrent.com/trials/effect-of-self-administered-tdcs-in-patients-with-mdd-119452https://curecurrent.com/trials/safety-and-efficacy-of-levomilnacipran-er-in-adolescent-participants-with-major-depressive-disorder-119453https://curecurrent.com/trials/efficacy-of-pythagorean-self-awareness-intervention-for-major-depressive-disorder-119454https://curecurrent.com/trials/study-comparing-magnetic-seizure-therapy-mst-to-electroconvulsive-therapy-ect-for-depression-in-older-adults-119455https://curecurrent.com/trials/study-of-rapastinel-as-monotherapy-in-patients-with-mdd-119456https://curecurrent.com/trials/effectiveness-of-ketamine-for-depression-and-suicidal-ideation-in-the-emergency-department-119457https://curecurrent.com/trials/pkc-as-serum-biomarkers-for-depression-119458https://curecurrent.com/trials/genecept-assay-vs-treatment-as-usual-to-evaluate-efficacy-of-assay-guided-treatment-in-adults-with-mdd-119459https://curecurrent.com/trials/optimization-of-diagnosis-and-treatment-of-depression-based-on-multidimensional-clinical-assessment-classification-119460https://curecurrent.com/trials/identifying-biological-markers-for-severe-depression-119461https://curecurrent.com/trials/active-reference-fluoxetine-fixed-dose-study-of-vortioxetine-in-paediatric-patients-aged-12-to-17-years-with-major-depre-119462https://curecurrent.com/trials/efficacy-and-safety-of-escitalopram-for-prevention-of-depression-induced-by-peg-interferon-in-hepatitis-c-patients-119463https://curecurrent.com/trials/a-study-of-rapastinel-for-rapid-treatment-of-depression-and-suicidality-in-major-depressive-disorder-119464https://curecurrent.com/trials/a-dose-escalation-phase-i-study-of-pdc-1421-capsule-targeting-in-depression-119465https://curecurrent.com/trials/bear-bile-pill-as-add-on-the-treatment-of-mdd-119466https://curecurrent.com/trials/the-safety-efficacy-and-tolerability-of-microbial-ecosystem-therapeutic-2-in-people-with-major-depression-and-or-general-119467https://curecurrent.com/trials/neurocognitive-outcomes-of-depression-in-the-elderly-119468https://curecurrent.com/trials/vortioxetine-for-treatment-of-depressive-mood-and-alcohol-use-119469https://curecurrent.com/trials/transcranial-direct-current-stimulation-in-major-depression-119470https://curecurrent.com/trials/prevalence-of-major-depression-among-immigrants-in-santiago-chile-119471https://curecurrent.com/trials/the-antidepressant-advisor-study-119472https://curecurrent.com/trials/brain-changes-in-severely-depressed-patients-before-and-after-treatment-with-electroconvulsive-therapy-119473https://curecurrent.com/trials/study-of-rapastinel-as-monotherapy-in-patients-with-major-depressive-disorder-mdd-119474https://curecurrent.com/trials/the-effect-of-s-ketamine-for-patients-undergoing-electroconvulsive-therapy-ect-119475https://curecurrent.com/trials/study-of-adjunctive-or-monotherapy-rapastinel-treatment-in-patients-with-major-depressive-disorder-mdd-119476https://curecurrent.com/trials/efficacy-of-h7-coil-dtms-compared-to-h1-coil-dtms-in-subjects-with-major-depression-disorder-mdd-119477https://curecurrent.com/trials/evaluation-of-the-brainsway-deep-transcranial-magnetic-stimulation-tms-h-coil-in-the-treatment-of-major-depression-disor-119478https://curecurrent.com/trials/prospective-multicenter-trial-to-explore-the-tolerability-and-safety-of-the-h-coil-deep-tms-in-combination-with-serotoni-119479https://curecurrent.com/trials/ketamine-infusion-for-adolescent-depression-and-anxiety-119480https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-ts-121-as-an-adjunctive-treatment-for-major-depressive-disorder-119481https://curecurrent.com/trials/establishing-tcm-daycare-model-and-teaching-mechanism-of-depression-patients-119482https://curecurrent.com/trials/pharmacogenetic-implementation-trial-in-veterans-with-treatment-refractory-depression-119483https://curecurrent.com/trials/combining-h1-coil-deep-transcranial-magnetic-stimulation-dtms-and-app-guided-cbt-in-subjects-with-major-depression-disor-119484https://curecurrent.com/trials/validation-study-mobile-dsst-on-cognition-in-adults-with-mdd-119485https://curecurrent.com/trials/pharmacogenomic-testing-to-optimize-antidepressant-drug-therapy-119486https://curecurrent.com/trials/mechanisms-of-antidepressant-non-response-in-late-life-depression-119487https://curecurrent.com/trials/neurofeedback-in-treatment-resistant-depression-119488https://curecurrent.com/trials/light-therapy-to-improve-symptoms-in-pregnant-women-with-major-depressive-disorder-119489https://curecurrent.com/trials/mineralocorticoid-receptor-nmda-receptor-and-cognitive-function-in-depression-119490https://curecurrent.com/trials/computerized-cognitive-behavior-therapy-in-treating-depression-in-patients-with-cancer-119491https://curecurrent.com/trials/long-term-safety-study-of-rapastinel-as-adjunctive-therapy-in-patients-with-major-depressive-disorder-119492https://curecurrent.com/trials/dimes-digital-medicine-study-for-adults-with-schizophrenia-bipolar-i-disorder-or-major-depression-currently-using-aripip-119493https://curecurrent.com/trials/the-antidiabetic-metformin-as-a-novel-adjunct-to-antidepressants-in-major-depressive-disorder-patients-119494https://curecurrent.com/trials/role-of-pentoxifylline-as-an-adjuvant-therapy-for-adult-patients-with-major-depressive-disorder-119495https://curecurrent.com/trials/brain-hippocampal-volume-relationship-with-anxious-symptoms-in-major-depressive-patients-119496https://curecurrent.com/trials/tdcs-intervention-on-motivational-anhedonia-of-major-depressive-disorder-119497https://curecurrent.com/trials/healthy-lifestyle-promotion-as-adjunctive-teletherapy-for-treatment-resistant-major-depression-119498https://curecurrent.com/trials/combinatorial-pharmacogenomics-testing-in-treatment-na-ve-major-depressive-disorder-119499https://curecurrent.com/trials/single-session-of-tacs-in-a-depressive-episode-119500https://curecurrent.com/trials/long-term-survivors-of-high-grade-glioma-and-their-caregivers-119501https://curecurrent.com/trials/disorder-tailored-transcranial-direct-current-stimulation-tdcs-of-the-prefrontal-cortex-119502https://curecurrent.com/trials/mediators-and-moderators-of-treatment-outcome-in-recent-onset-psychosis-119503https://curecurrent.com/trials/multifamily-psychoeducation-and-cognitive-remediation-for-recent-onset-psychosis-119504https://curecurrent.com/trials/social-cognition-in-longstanding-psychosis-119505https://curecurrent.com/trials/bipolar-proteomic-assay-validation-study-119506https://curecurrent.com/trials/comparison-of-anyu-peibo-with-placebo-in-treatment-of-mdd-in-china-119507https://curecurrent.com/trials/the-role-of-pkc-activation-in-the-immune-inflammatory-mechanism-of-major-depressive-depression-119508https://curecurrent.com/trials/pharmacogenomic-decision-support-with-genesight-psychotropic-to-guide-the-treatment-of-major-depressive-disorder-119509https://curecurrent.com/trials/cognitive-psychological-and-electrophysiological-attributes-to-suicide-among-depressed-patients-119510https://curecurrent.com/trials/efficacy-safety-and-pharmacokinetic-study-of-inhaled-esketamine-in-treatment-resistant-depression-119511https://curecurrent.com/trials/clinical-study-of-generic-and-brand-bupropion-in-depression-119512https://curecurrent.com/trials/study-of-naltrexone-induced-blockade-of-antidepressant-effects-119513https://curecurrent.com/trials/study-to-assess-the-effects-of-intranasal-ketamine-along-with-rtms-for-patients-with-treatment-resistant-major-depressiv-119514https://curecurrent.com/trials/intestinal-flora-and-major-depressive-disorders-119515https://curecurrent.com/trials/effects-of-antidepressant-therapy-on-brain-dopamine-transporter-activity-in-people-with-major-depression-119516https://curecurrent.com/trials/fecal-microbiota-transplantation-in-depression-119517https://curecurrent.com/trials/functional-change-and-efficacy-of-duloxetine-in-patients-with-co-morbid-depression-soft-tissue-discomfort-syndrome-119518https://curecurrent.com/trials/can-virtual-reality-reduce-depression-and-agitation-in-older-adults-with-moderate-to-severe-dementia-119519https://curecurrent.com/trials/molecular-imaging-of-brain-inflammation-in-depressive-disorders-119520https://curecurrent.com/trials/neosync-tms-treatment-for-bipolar-i-depression-119521https://curecurrent.com/trials/project-best-buprenorphine-entry-into-substance-abuse-treatment-119522https://curecurrent.com/trials/the-effect-of-ketamine-on-mechanises-underlying-suicidal-ideation-and-drug-resistant-major-depression-119523https://curecurrent.com/trials/intervention-targeting-motivational-negative-symptoms-119524https://curecurrent.com/trials/feasibility-of-a-behavioral-activation-trial-119525https://curecurrent.com/trials/neural-mechanisms-underlying-the-antidepressant-effects-of-sleep-deprivation-119526https://curecurrent.com/trials/study-with-vortioxetine-on-emotional-functioning-in-patients-with-depression-119527https://curecurrent.com/trials/clozapine-versus-olanzapine-as-treatment-for-comorbid-psychotic-disorder-and-substance-use-disorder-119528https://curecurrent.com/trials/treatment-for-cognitive-impairment-in-depression-119529https://curecurrent.com/trials/community-based-mental-health-care-for-people-with-severe-and-enduring-mental-ill-health-119530https://curecurrent.com/trials/study-to-learn-about-relapse-prevention-of-hypericumextract-a-drug-based-on-the-plant-st-john-wort-in-outpatients-suffer-119531https://curecurrent.com/trials/study-of-respiratory-depression-when-using-a-hydromorphone-pain-protocol-119532https://curecurrent.com/trials/the-role-of-cognitive-control-in-the-transdiagnostic-conceptualization-of-intrusive-thoughts-119533https://curecurrent.com/trials/translational-investigation-of-gestational-environment-on-neurobehavioral-function-in-children-119534https://curecurrent.com/trials/ketamine-for-suicidality-in-bipolar-depression-119535https://curecurrent.com/trials/a-transdiagnostic-sleep-and-circadian-treatment-for-major-depressive-disorder-119536https://curecurrent.com/trials/ketamine-in-the-treatment-of-suicidal-depression-119537https://curecurrent.com/trials/treating-emotional-disorders-in-primary-care-with-psychological-techniques-119538https://curecurrent.com/trials/placebo-effects-in-the-treatment-of-depression-cognitive-and-neural-mechanisms-119539https://curecurrent.com/trials/a-study-of-rapastinel-as-adjunctive-therapy-in-the-prevention-of-relapse-in-patients-with-major-depressive-disorder-119540https://curecurrent.com/trials/efficacy-and-tolerability-of-riluzole-in-treatment-resistant-depression-119541https://curecurrent.com/trials/developing-new-clinical-management-strategies-119542https://curecurrent.com/trials/incorporating-patient-treatment-choice-to-improve-treatment-retention-in-depressed-hispanics-119543https://curecurrent.com/trials/estrogen-and-perimenopausal-depression-119544https://curecurrent.com/trials/noninvasive-physiologic-sensors-to-assess-depression-119545https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-bupropion-hydrochloride-extended-release-tablet-and-escitalopr-119546https://curecurrent.com/trials/neural-components-underlying-the-treatment-of-adolescent-depression-119547https://curecurrent.com/trials/a-pilot-randomised-controlled-trial-of-a-health-champion-intervention-119548https://curecurrent.com/trials/self-help-smartphone-delivered-cognitive-behavioral-therapy-for-insomnia-in-people-with-depression-and-insomnia-119549https://curecurrent.com/trials/the-activation-on-prefrontal-cortex-with-acupuncture-and-moxibustion-for-major-depressive-disorder-a-study-of-functional-119550https://curecurrent.com/trials/scopolamine-in-healthy-volunteers-119551https://curecurrent.com/trials/efficacy-and-safety-of-accelerated-transcranial-magnetic-stimulation-with-h1-coil-dtms-119552https://curecurrent.com/trials/the-role-of-inflammatory-processes-in-development-and-treatment-of-depression-119553https://curecurrent.com/trials/functional-and-metabolic-changes-in-the-course-of-antidepressive-treatment-119554https://curecurrent.com/trials/vortioxetine-for-cancer-patients-with-depression-an-observational-study-119555https://curecurrent.com/trials/cognitive-therapy-to-sustain-the-antidepressant-effects-of-intravenous-ketamine-in-treatment-resistant-depression-119556https://curecurrent.com/trials/endogenous-opioid-modulation-by-ketamine-119557https://curecurrent.com/trials/ketamine-in-adolescents-with-treatment-resistant-depression-119558https://curecurrent.com/trials/nitrous-oxide-as-treatment-for-major-depression-a-pilot-study-119559https://curecurrent.com/trials/effectiveness-of-a-structured-physical-rehabilitation-program-for-chinese-patients-with-depressive-disorders-119560https://curecurrent.com/trials/ketamine-long-therm-follow-up-study-119561https://curecurrent.com/trials/effect-of-4-session-metacognitive-training-in-chinese-adult-outpatients-with-schizophrenia-spectrum-disorders-and-major-119562https://curecurrent.com/trials/ketamine-as-an-adjunctive-therapy-for-major-depression-119563https://curecurrent.com/trials/a-family-based-primary-care-intervention-to-enhance-older-men-s-depression-care-119564https://curecurrent.com/trials/genomics-used-to-improve-depression-decisions-119565https://curecurrent.com/trials/ketamine-for-relapse-prevention-in-recurrent-depressive-disorder-119566https://curecurrent.com/trials/relapse-prevention-study-with-levomilnacipran-er-f2695-sr-in-patients-with-major-depressive-disorder-119567https://curecurrent.com/trials/coil-positioning-in-navigated-transcranial-magnetic-stimulation-feasibility-in-depression-patients-trial-119568https://curecurrent.com/trials/efficacy-and-safety-of-s-47445-versus-placebo-as-adjunctive-treatment-in-depressed-patients-not-fully-recovered-from-dep-119569https://curecurrent.com/trials/comparative-effectiveness-clinical-trial-of-mst-compared-to-ect-in-major-depressive-disorder-119570https://curecurrent.com/trials/comparison-of-anyu-peibo-with-placebo-in-treatment-of-mdd-119571https://curecurrent.com/trials/deep-brain-stimulation-in-patients-with-chronic-treatment-resistant-depression-119572https://curecurrent.com/trials/a-study-of-rapastinel-as-adjunctive-therapy-in-major-depressive-disorder-rap-md-02-119573https://curecurrent.com/trials/a-kynurenine-pathway-based-molecular-imaging-study-of-individualized-diagnosis-and-treatment-for-major-depressive-disord-119574https://curecurrent.com/trials/safety-and-efficacy-of-vilazodone-in-adolescent-patients-with-major-depressive-disorder-119575https://curecurrent.com/trials/thinking-healthy-program-peer-delivered-pakistan-119576https://curecurrent.com/trials/a-study-of-individualized-diagnosis-and-treatment-for-major-depressive-disorder-with-atypical-features-119577https://curecurrent.com/trials/validity-and-reliability-of-vietnamese-version-of-17items-hamilton-depression-rating-scale-119578https://curecurrent.com/trials/ketamine-as-an-alternative-treatment-to-ect-in-major-depressive-disorder-119579https://curecurrent.com/trials/8-week-of-ps128-rct-in-patients-with-major-depressive-disorder-119580https://curecurrent.com/trials/gaze-contingent-feedback-in-major-depressive-disorder-mdd-119581https://curecurrent.com/trials/p11-protein-levels-in-patients-with-major-depressive-disorder-treated-with-citalopram-119582https://curecurrent.com/trials/brain-imaging-genetics-and-treatment-for-major-depression-119583https://curecurrent.com/trials/gaba-glutamate-balance-in-temporal-lobe-epilepsy-with-and-without-major-depression-119584https://curecurrent.com/trials/the-effects-of-estrogen-withdrawal-on-mood-symptoms-in-women-119585https://curecurrent.com/trials/brain-inflammation-in-major-depressive-disorder-background-119586https://curecurrent.com/trials/effects-of-tryptophan-depletion-on-brain-processing-of-emotions-in-patients-with-mood-disorders-119587https://curecurrent.com/trials/central-nervous-system-disease-in-hiv-infected-children-on-haart-119588https://curecurrent.com/trials/ketamine-in-the-treatment-of-depression-119589https://curecurrent.com/trials/brain-imaging-for-hiv-associated-thinking-and-mood-disorders-119590https://curecurrent.com/trials/a-prospective-study-of-postpartum-depression-in-women-with-major-depression-119591https://curecurrent.com/trials/melancholic-depression-and-insomnia-as-predictors-of-response-to-quetiapine-in-patients-with-major-depression-119592https://curecurrent.com/trials/brain-function-in-mentally-ill-adolescents-119593https://curecurrent.com/trials/willkommen-muttergl-ck-online-cbt-for-pregnant-and-postpartum-women-with-depression-and-anxiety-119594https://curecurrent.com/trials/differentiating-unipolar-and-bipolar-depression-in-young-adults-using-fmri-119595https://curecurrent.com/trials/a-randomized-controlled-trial-of-pcit-ed-for-preschool-depression-119596https://curecurrent.com/trials/comparison-of-the-efficacy-safety-and-relapse-of-ect-to-ect-plus-agomelatine-for-depressed-patients-119597https://curecurrent.com/trials/remotely-programmed-deep-brain-stimulation-of-the-bilateral-habenula-for-treatment-resistant-major-depression-an-open-la-119598https://curecurrent.com/trials/open-label-extension-for-glyx13-c-202-nct01684163-119599https://curecurrent.com/trials/examining-the-link-between-depression-and-seasonal-allergies-119600https://curecurrent.com/trials/predicting-effectiveness-of-light-treatment-for-winter-seasonal-affective-disorder-119601https://curecurrent.com/trials/efficacy-of-deep-anaesthesia-with-isoflurane-as-a-fast-response-antidepressant-agent-119602https://curecurrent.com/trials/treatment-of-severe-depressive-illness-by-targeted-brain-surgery-119603https://curecurrent.com/trials/depression-and-major-adverse-events-in-older-patients-who-undergo-a-transcatheter-aortic-valve-implantation-119604https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-adjunctive-pimavanserin-in-major-depressive-disorder-clarity-119605https://curecurrent.com/trials/a-study-of-rapastinel-as-adjunctive-therapy-in-major-depressive-disorder-rap-md-03-119606https://curecurrent.com/trials/a-trial-to-measure-the-difference-in-all-cause-hospitalizations-for-participants-who-are-using-abilify-mycite-versus-vir-119607https://curecurrent.com/trials/imaging-dopamine-release-in-depression-119608https://curecurrent.com/trials/post-marketing-study-for-the-evaluation-of-predictix-antidepressant-clinician-software-support-tool-in-prescribing-antid-119609https://curecurrent.com/trials/cortical-excitability-and-inhibition-in-mdd-119610https://curecurrent.com/trials/treatment-outcome-in-major-depressive-disorder-119611https://curecurrent.com/trials/brain-aging-and-treatment-response-in-geriatric-depression-119612https://curecurrent.com/trials/pattern-separation-brain-derived-neurotrophic-factors-and-mechanisms-of-vortioxetine-119613https://curecurrent.com/trials/a-study-of-rapastinel-as-adjunctive-therapy-in-major-depressive-disorder-rap-md-01-119614https://curecurrent.com/trials/theta-burst-stimulation-in-major-depressive-episodes-with-mixed-characteristics-119615https://curecurrent.com/trials/av-101-as-adjunct-antidepressant-therapy-in-patients-with-major-depression-119616https://curecurrent.com/trials/pharmacogenetic-morphine-spine-study-119617https://curecurrent.com/trials/the-treatment-of-depression-with-yoga-and-walking-119618https://curecurrent.com/trials/does-concurrent-hydrocortisone-with-venlafaxine-xr-speed-antidepressant-response-119619https://curecurrent.com/trials/investigate-efficacy-safety-of-ro4995819-vs-placebo-as-adjunct-tx-in-patients-w-major-depressive-disorder-119620https://curecurrent.com/trials/tms-for-adults-with-autism-and-depression-119621https://curecurrent.com/trials/safety-and-efficacy-of-vilazodone-in-pediatric-patients-with-major-depressive-disorder-vlz-md-22-119622https://curecurrent.com/trials/cognitive-behavioral-group-therapy-for-the-management-of-menopause-symptoms-in-mood-disorders-119623https://curecurrent.com/trials/the-effects-of-tdcs-on-depressive-symptoms-neurocognitive-function-and-hrv-in-unipolar-depression-and-bipolar-depression-119624https://curecurrent.com/trials/memantine-to-reduce-neurocognitive-deficits-following-unilateral-ect-for-the-treatment-of-a-major-depression-119625https://curecurrent.com/trials/neural-effects-of-wellness-classes-in-women-with-vulnerability-to-depression-the-women-s-wellness-study-119626https://curecurrent.com/trials/evaluation-of-metacognitive-training-for-depression-d-mct-in-outpatient-care-119627https://curecurrent.com/trials/sleep-wake-and-light-therapy-for-depression-119628https://curecurrent.com/trials/oxytocin-add-on-for-stable-depressed-patients-119629https://curecurrent.com/trials/heart-rate-variability-in-depression-119630https://curecurrent.com/trials/e-compared-s-comparative-effectiveness-research-on-internet-based-depression-treatment-spanish-trial-119631https://curecurrent.com/trials/escitalopram-plus-ps128-vs-escitalopram-119632https://curecurrent.com/trials/a-prediction-study-of-multiple-indexes-of-the-effect-of-different-mechanisms-of-antidepressants-treatment-on-depression-119633https://curecurrent.com/trials/a-study-of-vilazodone-in-pediatric-patients-with-major-depressive-disorder-119634https://curecurrent.com/trials/postpartum-depression-transdermal-estradiol-versus-sertraline-119635https://curecurrent.com/trials/improve-integrating-emotion-focused-components-into-psychological-therapy-119636https://curecurrent.com/trials/efficacy-of-adjunctive-exercise-for-the-behavioral-treatment-of-major-depression-119637https://curecurrent.com/trials/mood-patient-powered-research-network-moodnetwork-119638https://curecurrent.com/trials/flavanol-augmentation-for-antidepressant-non-responsive-late-life-depression-119639https://curecurrent.com/trials/procedures-for-sample-acquisition-and-distribution-for-the-human-brain-collection-core-119640https://curecurrent.com/trials/hypersomnia-in-major-depressive-disorder-119641https://curecurrent.com/trials/patient-stratification-and-treatment-response-prediction-in-neuropharmacotherapy-using-hybrid-positron-emmission-tomogra-119642https://curecurrent.com/trials/administration-of-subanesthetic-dose-of-ketamine-and-electroconvulsive-treatment-for-treatment-resistant-depression-119643https://curecurrent.com/trials/vortioxetine-intravenous-infusion-at-initiation-of-oral-treatment-with-vortioxetine-in-patients-with-depression-119644https://curecurrent.com/trials/rapid-antidepressant-effects-of-yohimbine-in-major-depression-119645https://curecurrent.com/trials/effect-of-short-term-mindfulness-based-training-for-major-depression-disorder-an-eye-tracking-study-119646https://curecurrent.com/trials/effects-of-ect-on-monoamine-oxidase-a-in-depression-investigated-with-pet-119647https://curecurrent.com/trials/riluzole-augmentation-pilot-in-depression-rapid-trial-119648https://curecurrent.com/trials/clinical-trial-of-the-effectiveness-of-metacognitive-therapy-in-the-treatment-of-patients-with-major-depressive-disorder-119649https://curecurrent.com/trials/stress-sensitivity-and-reward-responsivity-in-depression-119650https://curecurrent.com/trials/transdiagnostic-psychotherapy-for-veterans-with-mood-and-anxiety-disorders-119651https://curecurrent.com/trials/biomarkers-of-fast-acting-therapies-in-major-depression-119652https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-cariprazine-as-an-adjunctive-treatment-to-antidepressant-therapy-adt-in-patients-wit-119653https://curecurrent.com/trials/testing-the-value-of-smartphone-assessments-of-people-with-mood-disorders-119654https://curecurrent.com/trials/primary-care-internet-based-depression-prevention-for-adolescents-catch-it-also-known-as-promoting-adolescent-health-119655https://curecurrent.com/trials/long-term-safety-and-tolerability-of-cariprazine-as-an-adjunctive-treatment-to-antidepressant-therapy-in-patients-with-m-119656https://curecurrent.com/trials/bikram-yoga-and-aerobic-exercise-for-the-treatment-of-major-depression-119657https://curecurrent.com/trials/focal-electroconvulsive-therapy-for-depression-119658https://curecurrent.com/trials/a-study-of-alks-5461-for-the-treatment-of-major-depressive-disorder-mdd-the-forward-4-study-119659https://curecurrent.com/trials/levomilnacipran-er-vs-adjunctive-quetiapine-for-adults-with-inadequate-relief-with-ssris-in-mdd-119660https://curecurrent.com/trials/a-study-of-alks-5461-for-the-treatment-of-major-depressive-disorder-mdd-forward-5-study-119661https://curecurrent.com/trials/a-study-of-different-titration-schedules-of-alks-5461-in-adults-with-major-depressive-disorder-mdd-119662https://curecurrent.com/trials/trial-of-levomilnacipran-in-geriatric-depression-119663https://curecurrent.com/trials/modafinil-s-effects-on-cognition-in-remitted-mdd-119664https://curecurrent.com/trials/a-relative-bioavailability-food-effect-study-of-ly03005-119665https://curecurrent.com/trials/research-study-for-major-depressive-disorder-investigation-of-glutamate-medications-119666https://curecurrent.com/trials/acceptance-and-commitment-therapy-versus-cognitive-therapy-for-the-treatment-of-major-depressive-disorder-119667https://curecurrent.com/trials/characterization-of-the-prosocial-and-prosexual-effects-of-ghb-119668https://curecurrent.com/trials/time-to-remission-of-depressive-symptoms-with-combined-ssri-and-ramelteon-119669https://curecurrent.com/trials/controlled-study-to-evaluate-the-safety-and-efficacy-of-the-predictix-antidepressant-clinician-support-tool-119670https://curecurrent.com/trials/omega-3-polyunsaturated-fatty-acids-on-major-depressive-disorder-in-patients-with-cardiovascular-diseases-119671https://curecurrent.com/trials/a-trial-of-sertraline-vs-cbt-for-end-stage-renal-disease-patients-with-depression-ascend-119672https://curecurrent.com/trials/the-exploratory-study-to-investigate-the-effect-of-ramelteon-for-insomnia-patients-with-major-depressive-disorder-by-usi-119673https://curecurrent.com/trials/study-of-rapastinel-as-monotherapy-in-major-depressive-disorder-mdd-119674https://curecurrent.com/trials/ketamine-for-treatment-resistant-mdd-119675https://curecurrent.com/trials/ptsd-posttraumatic-stress-disorder-services-for-veterans-with-smi-severe-mental-illness-119676https://curecurrent.com/trials/goal-achievement-after-a-change-to-vortioxetine-in-adults-with-major-depressive-disorder-119677https://curecurrent.com/trials/effects-of-escitalopram-on-the-sleep-eeg-power-in-patients-with-major-depressive-disorder-119678https://curecurrent.com/trials/a-study-of-ly2216684-and-theophylline-in-healthy-subjects-119679https://curecurrent.com/trials/efficacy-of-intermittent-thetaburst-stimulation-compared-to-10-hz-stimulation-on-dorsolateral-prefrontal-cortex-in-treat-119680https://curecurrent.com/trials/fecal-microbiota-transplantation-119681https://curecurrent.com/trials/influenza-vaccine-as-a-novel-experimental-model-of-the-behavioral-immune-response-in-depression-119682https://curecurrent.com/trials/a-study-of-ly2216684-in-healthy-participants-119683https://curecurrent.com/trials/somatic-comorbidities-in-psychiatric-patients-119684https://curecurrent.com/trials/piloting-a-novel-mobile-cognitive-training-tool-for-patients-with-major-depressive-disorder-mdd-119685https://curecurrent.com/trials/storytelling-video-intervention-for-depressed-primary-care-patients-open-trial-119686https://curecurrent.com/trials/a-study-of-alks-5461-for-the-treatment-of-major-depressive-disorder-mdd-the-forward-3-study-119687https://curecurrent.com/trials/genetics-of-symptomatology-and-treatment-response-in-psychotic-major-depression-119688https://curecurrent.com/trials/the-efficacy-safety-and-tolerability-of-probiotics-on-the-mood-and-cognition-of-depressed-patients-119689https://curecurrent.com/trials/selective-serotonin-reuptake-inhibitors-ssris-in-borderline-personality-disorder-119690https://curecurrent.com/trials/integrating-pharmacogenomic-testing-into-a-child-psychiatry-clinic-119691https://curecurrent.com/trials/prediction-of-ssri-treatment-in-major-depression-119692https://curecurrent.com/trials/mechanisms-of-mindfulness-based-cognitive-therapy-in-the-treatment-of-recurrent-major-depressive-disorder-119693https://curecurrent.com/trials/buprenorphine-used-with-treatment-resistant-depression-in-older-adults-119694https://curecurrent.com/trials/attention-bias-modification-treatment-for-young-adults-with-major-depressive-disorder-119695https://curecurrent.com/trials/dichotic-listening-as-a-predictor-of-medication-response-in-depression-119696https://curecurrent.com/trials/chronotherapy-randomized-controlled-trial-119697https://curecurrent.com/trials/integrated-chronotherapy-for-perinatal-depression-119698https://curecurrent.com/trials/a-new-treatment-approach-for-major-depressive-disorder-based-upon-targeting-monoamine-oxidase-a-mao-a-119699https://curecurrent.com/trials/neuroimaging-mao-b-in-medication-free-tr-mdd-using-novel-tracer-119700https://curecurrent.com/trials/biomarkers-of-neuroinflammation-and-anti-inflammatory-treatments-in-major-depressive-disorder-119701https://curecurrent.com/trials/noradrenergic-activity-cognition-and-major-depressive-disorder-119702https://curecurrent.com/trials/clinical-impact-of-the-antidepressant-pharmacogenomic-algorithm-in-an-outpatient-therapy-based-clinical-setting-119703https://curecurrent.com/trials/a-study-to-evaluate-alks-5461-in-subjects-with-major-depressive-disorder-mdd-119704https://curecurrent.com/trials/the-safety-and-efficacy-of-naltrexone-and-scopolamine-utilized-in-the-treatment-of-major-depression-119705https://curecurrent.com/trials/the-effects-of-e-mental-health-program-and-job-coaching-on-the-risk-of-major-depression-in-canadian-working-men-119706https://curecurrent.com/trials/neuro-cardiac-guided-transcranial-magnetic-stimulation-replication-and-dose-response-119707https://curecurrent.com/trials/african-american-depression-intervention-trial-aadi-119708https://curecurrent.com/trials/restoring-emotion-regulation-networks-in-depression-vulnerability-119709https://curecurrent.com/trials/secondary-prevention-of-depression-applying-an-experimental-attentional-bias-modification-procedure-119710https://curecurrent.com/trials/investigation-of-genetic-predictors-of-the-response-to-selective-serotonin-re-uptake-inhibitors-ssri-treatment-119711https://curecurrent.com/trials/ketamine-for-major-depressive-disorder-119712https://curecurrent.com/trials/smartphone-enabled-health-coaching-intervention-for-youth-diagnosed-with-major-depressive-disorders-119713https://curecurrent.com/trials/pulsed-electro-magnetic-fields-pemf-in-depression-119714https://curecurrent.com/trials/genetics-of-recurrent-early-onset-major-depression-119715https://curecurrent.com/trials/dbs-for-treatment-resistant-depression-119716https://curecurrent.com/trials/switching-from-ssri-to-desvenlafaxine-on-cognitive-functioning-119717https://curecurrent.com/trials/a-comparison-of-medication-augmentation-and-pst-in-the-treatment-of-depression-in-older-adults-119718https://curecurrent.com/trials/clinical-trial-of-cbasp-for-individuals-with-co-occurring-chronic-depression-and-alcohol-dependence-119719https://curecurrent.com/trials/antidepressive-effect-on-5-herz-hz-rtms-over-dorsomedial-prefrontal-cortex-and-left-dorsolateral-prefrontal-cortex-119720https://curecurrent.com/trials/ketamine-for-depression-an-mri-study-119721https://curecurrent.com/trials/study-to-treat-major-depressive-disorder-mdd-with-a-new-medication-119722https://curecurrent.com/trials/deficits-in-emotion-regulation-skills-as-a-maintaining-factor-in-major-depressive-disorder-119723https://curecurrent.com/trials/aripiprazole-abilify-as-an-adjunctive-treatment-for-inadequate-response-in-major-depressive-disorder-119724https://curecurrent.com/trials/citalopram-titration-in-early-non-responder-patients-with-major-depressive-disorders-119725https://curecurrent.com/trials/study-on-the-effect-of-prkcb1-modulating-inflammatory-factors-and-the-role-for-developing-major-depressive-disorder-119726https://curecurrent.com/trials/confirmation-bias-towards-treatments-of-depressive-disorders-in-social-tagging-119727https://curecurrent.com/trials/predictors-of-depression-treatment-response-to-exercise-119728https://curecurrent.com/trials/attention-bias-modification-treatment-for-major-depressive-disorder-in-adolescents-119729https://curecurrent.com/trials/community-based-mental-health-care-for-people-with-severe-and-enduring-mental-iii-health-recover-e-119730https://curecurrent.com/trials/behavior-during-experimentally-induced-pain-119731https://curecurrent.com/trials/study-of-brexpiprazole-as-adjunctive-treatment-of-sleep-disturbances-in-patients-with-major-depressive-disorder-119732https://curecurrent.com/trials/a-multimodal-neuroimaging-study-of-brain-activation-patterns-under-ketamine-119733https://curecurrent.com/trials/pre-treatment-positron-emission-topography-scanning-for-increasing-success-in-antidepressant-treatment-119734https://curecurrent.com/trials/the-effect-of-probiotic-supplementation-on-the-mental-status-inflammation-and-intestinal-barrier-in-major-depressive-dis-119735https://curecurrent.com/trials/clinical-effect-of-dtms-in-major-depressive-disorder-119736https://curecurrent.com/trials/tbs-in-major-depression-119737https://curecurrent.com/trials/understanding-how-cognitive-remediation-works-119738https://curecurrent.com/trials/n-3-fatty-acids-as-the-first-line-antidepressant-therapy-from-biomarkers-to-clinical-subtypes-119739https://curecurrent.com/trials/a-study-of-the-effect-of-ly2216684-on-lorazepam-119740https://curecurrent.com/trials/lithium-therapeutic-drug-monitoring-once-daily-vs-twice-daily-dosing-and-the-impact-of-kidney-function-119741https://curecurrent.com/trials/safety-and-efficacy-of-cariprazine-as-adjunctive-therapy-in-major-depressive-disorder-119742https://curecurrent.com/trials/community-based-mental-health-care-for-people-with-severe-and-enduring-mental-ill-health-recover-e-croatia-119743https://curecurrent.com/trials/a-six-week-randomized-double-blind-placebo-controlled-suvorexant-augmentation-study-of-antidepressant-treatment-of-major-119744https://curecurrent.com/trials/design-and-methods-of-the-mood-disorder-cohort-research-consortium-mdcrc-study-119745https://curecurrent.com/trials/person-centered-versus-measurement-based-care-in-mental-health-119746https://curecurrent.com/trials/machine-learning-to-predict-clinical-response-to-tms-119747https://curecurrent.com/trials/laughter-yoga-intervention-for-people-with-major-depressive-disorder-119748https://curecurrent.com/trials/effects-of-tdcs-enhanced-cognitive-control-training-on-depression-119749https://curecurrent.com/trials/metabolism-variability-of-venlafaxine-119750https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-for-treating-depression-a-functional-magnetic-resonance-imaging-study-119751https://curecurrent.com/trials/augmentation-of-treatment-resistant-depression-with-an-analog-of-the-neuroactive-steroid-allopregnanolone-119752https://curecurrent.com/trials/transdiagnostic-icbt-for-depression-and-anxiety-119753https://curecurrent.com/trials/pharmacogenetic-decision-support-it-system-for-psychiatric-hospitalization-rct-119754https://curecurrent.com/trials/using-neuroimaging-to-investigate-major-depressive-disorder-119755https://curecurrent.com/trials/electronic-measurement-based-care-for-major-depressive-disorder-119756https://curecurrent.com/trials/study-of-323u66-sr-in-major-depressive-disorder-119757https://curecurrent.com/trials/a-study-to-measure-if-there-is-any-difference-in-how-the-body-breaks-down-or-inactivates-either-fluoxetine-or-ly2216684-119758https://curecurrent.com/trials/a-study-of-ly2216684-in-healthy-participants-receiving-albuterol-or-propanolol-119759https://curecurrent.com/trials/reducing-residual-depressive-symptoms-with-web-based-mindful-mood-balance-119760https://curecurrent.com/trials/imaging-antidepressant-vs-cognitive-behavior-therapy-effects-on-unipolar-depression-119761https://curecurrent.com/trials/comparison-of-anyu-peibo-with-placebo-in-treatment-of-mdd-b-119762https://curecurrent.com/trials/a-study-of-ly2216684-and-warfarin-in-healthy-subjects-119763https://curecurrent.com/trials/sleep-and-survival-in-colorectal-cancer-119764https://curecurrent.com/trials/a-study-of-dvs-sr-in-treatment-of-children-and-adolescent-outpatients-with-mdd-119765https://curecurrent.com/trials/cognitive-and-mood-assessment-data-in-major-depressive-disorder-using-digital-wearable-technology-119766https://curecurrent.com/trials/rescuing-the-ruminating-brain-identifying-biomarkers-of-rumination-and-mindfulness-through-concurrent-eeg-and-functional-119767https://curecurrent.com/trials/cognitive-dysfunction-in-mdd-patients-119768https://curecurrent.com/trials/a-pharmacokinetic-study-of-the-coadministration-of-ly2216684-with-sertraline-119769https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-activated-charcoal-on-the-absorption-of-ly2216684-in-healthy-subjects-119770https://curecurrent.com/trials/identification-of-multi-modal-bio-markers-for-early-diagnosis-and-treatment-prediction-in-schizophrenia-individuals-119771https://curecurrent.com/trials/effectiveness-study-of-scopolamine-combined-with-escitalopram-in-patients-with-mdd-119772https://curecurrent.com/trials/establishing-moderators-and-biosignatures-of-antidepressant-response-for-clinical-care-for-depression-119773https://curecurrent.com/trials/neurophysiologic-correlates-of-hypersomnia-119774https://curecurrent.com/trials/dose-finding-clinical-trial-to-evaluate-the-efficacy-and-safety-of-ly03005-extended-release-tablets-in-the-treatment-of-119775https://curecurrent.com/trials/bioequivalence-study-of-paroxetine-tablets-and-paxil-under-fasting-and-fed-conditions-in-chinese-healthy-volunteers-119776https://curecurrent.com/trials/fevarin-effectiveness-in-treatment-of-depression-in-patients-with-neurological-disorder-119777https://curecurrent.com/trials/a-long-term-safety-study-of-alks-5461-119778https://curecurrent.com/trials/feasibility-study-to-test-clinical-efficacy-of-low-energy-ac-magnetic-field-to-treat-major-depression-119779https://curecurrent.com/trials/study-evaluating-long-term-safety-of-desvenlafaxine-succinate-sustained-release-with-japanese-adult-subjects-in-major-de-119780https://curecurrent.com/trials/brain-derived-neurotropic-factor-response-to-aerobic-exercise-intensity-in-depressive-patients-119781https://curecurrent.com/trials/effect-of-vitamin-d-administration-along-with-ssris-in-patients-with-major-depressive-disorder-119782https://curecurrent.com/trials/software-treatments-for-actively-reducing-severity-of-cognitive-deficits-in-mdd-stars-mdd-119783https://curecurrent.com/trials/comparing-mobile-health-mhealth-and-clinic-based-self-management-interventions-for-serious-mental-illness-119784https://curecurrent.com/trials/the-impact-of-depression-and-or-anxiety-on-pci-patients-119785https://curecurrent.com/trials/neuroqore-rtms-monophasic-vs-biphasic-for-major-depressive-disorder-a-randomized-controlled-pilot-trial-119786https://curecurrent.com/trials/depression-management-project-119787https://curecurrent.com/trials/healthy-mood-internet-intervention-research-project-119788https://curecurrent.com/trials/enhancing-the-effectiveness-of-electroconvulsive-therapy-in-severe-depression-119789https://curecurrent.com/trials/stress-management-and-resiliency-training-smart-integrated-into-treatment-of-major-depression-119790https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-food-on-ly2216684-119791https://curecurrent.com/trials/a-study-of-ly03005-vs-pristiq-119792https://curecurrent.com/trials/safety-and-efficacy-of-mk-6096-as-adjunctive-therapy-in-participants-with-major-depressive-disorder-and-partial-response-119793https://curecurrent.com/trials/the-role-of-expectations-in-the-pharmacological-treatment-of-depression-an-experimental-investigation-119794https://curecurrent.com/trials/trial-to-determine-the-maximum-tolerated-dose-mtd-based-on-safety-and-tolerability-of-org-26576-in-participants-with-maj-119795https://curecurrent.com/trials/role-of-omega-3-polyunsaturated-fatty-acid-in-the-management-of-major-depressive-disorder-119796https://curecurrent.com/trials/dismantling-mindfulness-contributions-of-attention-vs-acceptance-119797https://curecurrent.com/trials/get-moving-and-get-well-pilot-study-119798https://curecurrent.com/trials/clinical-and-suicidal-features-of-urban-turkish-middle-age-depressive-patients-with-comorbid-adhd-119799https://curecurrent.com/trials/paroxetine-bupropion-in-suicide-attempters-ideators-with-major-depression-119800https://curecurrent.com/trials/a-phase-1-study-to-investigate-the-pharmacokinetics-safety-and-tolerability-of-cp-601-927-in-healthy-japanese-subjects-119801https://curecurrent.com/trials/a-multicenter-relapse-prevention-study-with-levomilnacipran-extended-release-er-in-participants-with-major-depressive-di-119802https://curecurrent.com/trials/emotional-brain-networks-cognitive-functioning-in-depression-and-anxiety-119803https://curecurrent.com/trials/the-process-outcome-mindfulness-effects-in-trainees-promet-study-119804https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-genotype-on-ly2216684-119805https://curecurrent.com/trials/a-trial-of-dextromethorphan-for-treatment-of-major-depressive-disorder-119806https://curecurrent.com/trials/a-study-of-ly2216684-in-participants-with-major-depression-disorder-119807https://curecurrent.com/trials/a-study-of-ly2216684-in-healthy-females-119808https://curecurrent.com/trials/a-study-of-ly2216684-in-major-depressive-disorder-in-patients-taking-selective-serotonin-reuptake-inhibitors-119809https://curecurrent.com/trials/a-study-of-ly2216684-in-participants-with-impaired-hepatic-function-119810https://curecurrent.com/trials/a-pharmacokinetic-study-on-the-effect-of-ly2216684-on-the-active-metabolite-of-clopidogrel-119811https://curecurrent.com/trials/a-study-of-ly2216684-and-digoxin-in-healthy-subjects-119812https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-clarithromycin-on-ly2216684-119813https://curecurrent.com/trials/group-metacognitive-therapy-vs-clinical-management-for-depression-119814https://curecurrent.com/trials/an-eye-tracking-study-of-affective-disorder-patients-with-suicide-risk-119815https://curecurrent.com/trials/long-term-safety-and-tolerability-study-of-brexpiprazole-as-adjunctive-treatment-in-patients-with-major-depressive-disor-119816https://curecurrent.com/trials/efficacy-and-safety-of-brexpiprazole-as-adjunctive-treatment-in-elderly-patients-with-major-depressive-disorder-with-an-119817https://curecurrent.com/trials/zaleplon-in-hiv-patients-with-depression-119818https://curecurrent.com/trials/sequential-use-of-fluoxetine-for-smokers-with-elevated-depressive-symptoms-119819https://curecurrent.com/trials/characterization-of-microbial-immune-and-epigenetic-biomarkers-for-major-depressive-disorder-and-ect-treatment-119820https://curecurrent.com/trials/the-study-of-mindfulness-based-cognitive-therapy-and-major-depressive-disorder-119821https://curecurrent.com/trials/rapid-antidepressant-effects-of-ketamine-in-major-depression-119822https://curecurrent.com/trials/subgenual-cg25-deep-brain-stimulation-in-severe-resistant-depression-119823https://curecurrent.com/trials/feasibility-of-a-technology-based-treatment-support-system-119824https://curecurrent.com/trials/rtms-for-ptsd-comorbid-with-major-depressive-disorder-119825https://curecurrent.com/trials/depressed-mood-improvement-through-nicotine-dosing-depressed-mind-study-119826https://curecurrent.com/trials/tapering-off-antidepressants-119827https://curecurrent.com/trials/peripheral-immunomarker-validation-in-treatment-resistant-depression-119828https://curecurrent.com/trials/efficacy-of-cognitive-behavioral-to-hypnotherapeutic-treatment-of-depression-119829https://curecurrent.com/trials/extension-study-of-the-safety-and-efficacy-of-armodafinil-treatment-as-adjunctive-therapy-in-adults-with-major-depressio-119830https://curecurrent.com/trials/games-to-overcome-late-life-depression-119831https://curecurrent.com/trials/improving-therapeutic-learning-in-depression-proof-of-concept-119832https://curecurrent.com/trials/using-a-low-dose-of-ketamine-vs-active-placebo-in-treating-severe-depression-and-suicide-119833https://curecurrent.com/trials/safety-and-tolerability-of-oral-opc-34712-as-adjunctive-therapy-in-adults-with-major-depressive-disorder-the-orion-trial-119834https://curecurrent.com/trials/low-field-magnetic-stimulation-for-treatment-resistant-depression-119835https://curecurrent.com/trials/ketamine-co-induction-for-patients-with-major-depressive-disorder-119836https://curecurrent.com/trials/a-study-to-evaluate-pharmacokinetics-safety-and-tolerability-of-extended-release-bupropion-hydrochloride-tablets-in-chin-119837https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-as-an-add-on-therapy-for-treatment-of-major-depressive-disorder-deptdcs2014-119838https://curecurrent.com/trials/antidepressant-mechanisms-of-transcranial-magnetic-stimulation-119839https://curecurrent.com/trials/adding-an-insulin-sensitizing-medication-to-depression-treatment-for-people-who-are-depressed-and-overweight-119840https://curecurrent.com/trials/effect-of-lactobacillus-plantarum-299v-supplementation-on-major-depression-treatment-119841https://curecurrent.com/trials/lexapro-s-efficacy-after-dose-escalation-in-remission-study-119842https://curecurrent.com/trials/naltrexone-plus-ketamine-for-the-rapid-treatment-of-major-depressive-disorder-and-alcohol-use-disorder-119843https://curecurrent.com/trials/prevention-of-ptsd-iii-neurocognitive-training-of-emotional-regulation-119844https://curecurrent.com/trials/coupling-repetitive-transcranial-magnetic-stimulation-with-a-neuronavigation-system-in-treatment-resistant-depression-119845https://curecurrent.com/trials/incomplete-response-in-late-life-depression-getting-to-remission-with-buprenorphine-119846https://curecurrent.com/trials/remote-cognitive-remediation-for-depression-119847https://curecurrent.com/trials/targeting-cognitive-immunization-in-depression-119848https://curecurrent.com/trials/multidomain-intervention-for-older-adults-with-major-depressive-disorder-119849https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-fixed-dose-brexpiprazole-opc-34712-as-adjunctive-therapy-in-the-treatment-of-adults-119850https://curecurrent.com/trials/transcranial-alternating-current-stimulation-for-major-depressive-disorder-119851https://curecurrent.com/trials/cognitive-training-to-enhance-va-work-program-outcomes-119852https://curecurrent.com/trials/a-fixed-dose-study-of-323u66-sr-in-the-treatment-of-major-depressive-disorder-mdd-119853https://curecurrent.com/trials/pilot-study-comparing-10hz-vs-theta-burst-stimulation-119854https://curecurrent.com/trials/biomarkers-of-theta-burst-stimulation-in-major-depressive-disorder-119855https://curecurrent.com/trials/effect-of-food-gender-and-age-on-the-pharmacokinetic-profile-of-suvn-911-in-healthy-subjects-119856https://curecurrent.com/trials/icare4depression-effectiveness-of-a-blended-cognitive-behavioral-therapy-in-routine-practice-119857https://curecurrent.com/trials/deep-brain-stimulation-of-the-superolateral-branch-of-the-medial-forebrain-bundle-slmfb-for-the-treatment-of-refractory-119858https://curecurrent.com/trials/magnetic-seizure-therapy-mst-for-treatment-resistant-major-depression-119859https://curecurrent.com/trials/effects-of-deep-brain-stimulation-in-treatment-resistant-major-depression-119860https://curecurrent.com/trials/brain-imaging-techniques-that-predict-antidepressant-responsiveness-119861https://curecurrent.com/trials/home-administered-trial-of-direct-current-stimulation-119862https://curecurrent.com/trials/ketamine-plus-lithium-in-treatment-resistant-depression-119863https://curecurrent.com/trials/transcranial-magnetic-stimulation-study-of-cortical-excitability-as-marker-of-antidepressant-response-excipsy-study-119864https://curecurrent.com/trials/incomplete-response-in-late-life-depression-getting-to-remission-with-buprenorphine-119865https://curecurrent.com/trials/a-pilot-study-on-repetitive-transcranial-magnetic-stimulation-rtms-treatment-of-bipolar-depression-119866https://curecurrent.com/trials/probing-prefrontal-cortex-hemodynamic-alterations-for-major-depression-disorder-119867https://curecurrent.com/trials/bupropion-for-depression-in-esrd-patients-on-hemodialysis-119868https://curecurrent.com/trials/management-strategy-for-mild-to-moderate-major-depression-combination-of-rhodiola-and-saffron-extracts-119869https://curecurrent.com/trials/fmri-study-of-treatment-changes-in-major-depression-119870https://curecurrent.com/trials/fmri-studies-of-emotional-brain-circuitry-in-people-with-major-depression-119871https://curecurrent.com/trials/berlin-magnetic-seizure-therapy-depression-trial-01-119872https://curecurrent.com/trials/international-study-to-predict-optimised-treatment-in-depression-119873https://curecurrent.com/trials/memantine-augmentation-of-antidepressants-119874https://curecurrent.com/trials/lexapro-for-major-depression-in-patients-with-epilepsy-119875https://curecurrent.com/trials/a-pilot-study-of-tms-effects-on-pain-and-depression-in-patients-with-fibromyalgia-119876https://curecurrent.com/trials/pet-imaging-of-brain-mglur1-receptors-using-18f-fimx-119877https://curecurrent.com/trials/examination-of-brain-serotonin-receptors-in-patients-with-mood-disorders-119878https://curecurrent.com/trials/antidepressant-effects-on-camp-specific-phosphodiesterase-pde4-in-depressed-patients-119879https://curecurrent.com/trials/lactobacillus-plantarum-ps128-in-patients-with-major-depressive-disorder-and-high-level-of-inflammation-119880https://curecurrent.com/trials/internet-delivered-psychotherapy-for-depression-119881https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-initial-administration-of-17-mg-vortioxetine-intravenously-with-10-mg-day-vortioxeti-119882https://curecurrent.com/trials/double-blind-placebo-controlled-trial-of-ketamine-therapy-in-treatment-resistant-depression-trd-119883https://curecurrent.com/trials/improving-representative-payeeship-for-people-with-psychiatric-disabilities-and-their-families-119884https://curecurrent.com/trials/tdcs-as-add-on-treatment-to-cognitive-behavior-therapy-in-people-with-mdd-119885https://curecurrent.com/trials/nuedexta-in-treatment-resistant-major-depression-119886https://curecurrent.com/trials/a-study-of-flexible-dose-brexpiprazole-as-adjunctive-therapy-in-the-treatment-of-adults-with-major-depressive-disorder-t-119887https://curecurrent.com/trials/testosterone-antidepressant-augmentation-in-women-119888https://curecurrent.com/trials/ketamine-anesthesia-for-improvement-of-depression-in-ect-119889https://curecurrent.com/trials/motivational-interviews-for-depression-in-primary-care-119890https://curecurrent.com/trials/evaluation-of-the-h1-coil-tms-double-blind-placebo-controlled-study-in-adolescent-patients-suffering-from-major-depressi-119891https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-and-pharmacokinetics-of-suvn-911-in-healthy-subjects-119892https://curecurrent.com/trials/va-augmentation-and-switching-treatments-for-improving-depression-outcomes-119893https://curecurrent.com/trials/predictors-of-the-outcome-of-late-life-depression-119894https://curecurrent.com/trials/a-multi-level-life-span-characterization-of-adult-depression-and-effects-of-medication-and-exercise-119895https://curecurrent.com/trials/exploratory-trial-to-assess-the-functionality-of-an-integrated-call-center-for-the-digital-medicine-system-119896https://curecurrent.com/trials/depression-and-dopamine-transporter-function-study-using-c-11-altropane-119897https://curecurrent.com/trials/assess-the-efficacy-and-safety-of-asc-01-in-patients-with-major-depressive-disorder-119898https://curecurrent.com/trials/biological-markers-of-response-to-treatment-in-major-depressive-disorder-119899https://curecurrent.com/trials/canadian-biomarker-integration-network-for-depression-study-119900https://curecurrent.com/trials/family-based-treatment-of-depressed-adolescents-ahus-119901https://curecurrent.com/trials/vilazodone-for-treatment-of-geriatric-depression-119902https://curecurrent.com/trials/non-invasive-brain-stimulation-and-cognitive-processing-in-depression-119903https://curecurrent.com/trials/investigating-the-mechanisms-of-mindfulness-based-cognitive-therapy-mbct-119904https://curecurrent.com/trials/combined-sertraline-and-ketoprofen-administration-in-major-depressive-disorder-119905https://curecurrent.com/trials/exploring-biomarkers-for-depression-119906https://curecurrent.com/trials/internet-delivered-cognitive-behavior-therapy-for-anxiety-and-depression-amongst-french-canadians-119907https://curecurrent.com/trials/safety-and-efficacy-of-cariprazine-as-an-adjunctive-to-antidepressant-therapy-in-major-depressive-disorder-119908https://curecurrent.com/trials/dichotic-listening-as-a-predictor-of-medication-response-in-depression-119909https://curecurrent.com/trials/a-study-in-participants-with-major-depressive-disorder-who-are-partial-responders-to-selective-serotonin-reuptake-inhibi-119910https://curecurrent.com/trials/a-study-for-participants-with-major-depression-119911https://curecurrent.com/trials/the-effects-of-dopamine-on-reward-processing-119912https://curecurrent.com/trials/a-study-of-flexible-or-fixed-dose-ly2216684-as-adjunctive-treatment-for-participants-with-major-depressive-disorder-who-119913https://curecurrent.com/trials/a-study-of-adjunctive-treatment-to-antidepressant-therapy-for-adults-with-major-depressive-disorder-119914https://curecurrent.com/trials/the-role-of-omega-3-fatty-acids-in-adolescent-depression-119915https://curecurrent.com/trials/clinical-and-biological-markers-of-response-to-cognitive-behavioural-therapy-for-depression-119916https://curecurrent.com/trials/the-efficacy-and-cognitive-impairment-of-modified-electroconvulsive-therapy-119917https://curecurrent.com/trials/an-eight-week-study-to-evaluate-the-efficacy-and-safety-of-saredutant-in-patients-with-depression-119918https://curecurrent.com/trials/dopaminergic-effects-of-adjunctive-aripiprazole-on-the-brain-in-treatment-resistant-depression-119919https://curecurrent.com/trials/a-study-in-prevention-of-re-emergence-of-depression-symptoms-119920https://curecurrent.com/trials/a-safety-study-in-participants-with-major-depressive-disorder-119921https://curecurrent.com/trials/using-affective-differences-to-predict-response-to-behavioral-treatment-for-major-depressive-disorder-119922https://curecurrent.com/trials/a-fixed-dose-study-of-adjunctive-treatment-to-antidepressant-therapy-for-adults-with-major-depressive-disorder-119923https://curecurrent.com/trials/beat-the-blues-in-pregnancy-study-transcranial-magnetic-stimulation-119924https://curecurrent.com/trials/brain-imaging-of-rtms-treatment-for-depression-119925https://curecurrent.com/trials/high-frequency-vs-low-frequency-vs-sham-dmpfc-rtms-for-major-depression-119926https://curecurrent.com/trials/fmri-neuronavigated-rtms-for-the-treatment-of-major-depression-associated-with-tbi-119927https://curecurrent.com/trials/maintenance-transcranial-electrical-stimulation-for-depression-119928https://curecurrent.com/trials/a-randomised-controlled-clinical-trial-of-memory-specificity-training-mest-for-depression-119929https://curecurrent.com/trials/sertraline-in-generalized-social-phobia-with-co-occurring-anxiety-and-mood-disorders-119930https://curecurrent.com/trials/microbiome-of-depression-treatment-response-to-citalopram-119931https://curecurrent.com/trials/dorsomedial-rtms-for-depression-in-borderline-personality-disorder-119932https://curecurrent.com/trials/a-study-in-adult-patients-with-major-depressive-disorder-119933https://curecurrent.com/trials/safety-and-efficacy-study-in-patients-with-major-depressive-disorder-119934https://curecurrent.com/trials/randomized-placebo-controlled-multicenter-trial-of-lithium-plus-treatment-as-usual-tau-for-acute-suicidal-ideation-and-b-119935https://curecurrent.com/trials/tranylcypromine-treatment-of-bipolar-depression-119936https://curecurrent.com/trials/comparing-different-patterns-of-rtms-in-major-depression-119937https://curecurrent.com/trials/my-depression-wellness-toolkit-study-119938https://curecurrent.com/trials/severe-fatigue-in-stem-cell-transplantation-119939https://curecurrent.com/trials/the-effectiveness-of-rtms-in-depressed-va-patients-119940https://curecurrent.com/trials/buprenorphine-for-treatment-resistant-depression-119941https://curecurrent.com/trials/examining-the-feasibility-and-effectiveness-of-case-manager-delivered-problem-solving-therapy-on-late-life-depression-119942https://curecurrent.com/trials/an-open-label-trial-of-duloxetine-for-the-treatment-of-irritable-bowel-syndrome-119943https://curecurrent.com/trials/buprenorphine-for-late-life-treatment-resistant-depression-119944https://curecurrent.com/trials/agomelatine-treatment-of-depression-in-schizophrenia-agopsych-119945https://curecurrent.com/trials/acupuncture-in-depression-from-the-clinical-trial-biomarkers-to-molecular-biology-119946https://curecurrent.com/trials/exercise-for-depression-119947https://curecurrent.com/trials/e-aid-sleep-focused-treatment-for-prevention-of-major-depression-step-md-119948https://curecurrent.com/trials/study-of-ibuprofen-effects-on-brain-function-119949https://curecurrent.com/trials/rhodiola-rosea-therapy-of-major-depressive-disorder-119950https://curecurrent.com/trials/ketamine-and-scopolamine-infusions-for-treatment-resistant-major-depressive-disorder-119951https://curecurrent.com/trials/efficacy-of-extended-release-quetiapine-seroquel-xr-as-adjunctive-therapy-to-cognitive-behavioral-therapy-in-the-treat-119952https://curecurrent.com/trials/effects-of-low-dose-ketamine-given-at-induction-of-anesthesia-on-postoperative-mood-in-patients-with-depressive-symptoms-119953https://curecurrent.com/trials/inflammation-and-electroconvulsive-therapy-119954https://curecurrent.com/trials/a-7-year-assessment-on-subject-understanding-of-zyban-wellbutrin-associated-risks-119955https://curecurrent.com/trials/movement-for-depression-an-rct-assessing-the-effects-of-physical-activity-promotion-for-people-with-mdd-119956https://curecurrent.com/trials/self-management-for-anxiety-depression-and-somatoform-disorders-119957https://curecurrent.com/trials/study-of-rotatory-vestibular-tests-in-major-depression-patients-and-healthy-control-subjects-119958https://curecurrent.com/trials/mdd-poc-study-gsk372475-subjects-depressive-disease-119959https://curecurrent.com/trials/yoga-for-young-women-with-depression-119960https://curecurrent.com/trials/assessment-in-work-productivity-and-the-relationship-with-cognitive-symptoms-in-patients-with-mdd-taking-vortioxetine-119961https://curecurrent.com/trials/5-hydroxytryptophan-and-creatine-for-treatment-resistant-depression-associated-with-hypoxia-in-females-119962https://curecurrent.com/trials/berlin-deep-brain-stimulation-depression-study-119963https://curecurrent.com/trials/community-based-integrated-treatment-for-adolescents-119964https://curecurrent.com/trials/influenza-challenge-in-mood-disorders-119965https://curecurrent.com/trials/the-serotonin-transporter-availability-for-prognosing-major-depressive-disorder-mdd-treatment-and-detecting-mdd-119966https://curecurrent.com/trials/memantine-treatment-for-improving-rehabilitation-outcomes-and-preventing-depression-in-older-adults-119967https://curecurrent.com/trials/comparison-of-anodal-transcranial-direct-current-stimulation-t-dcs-and-sham-stimulation-in-patients-with-treatment-resis-119968https://curecurrent.com/trials/effectiveness-of-methylphenidate-in-improving-cognition-and-function-in-older-adults-with-depression-119969https://curecurrent.com/trials/vitamin-d-ssris-and-the-musculoskeletal-system-119970https://curecurrent.com/trials/neurocardiac-interactions-evaluated-by-anatomic-and-physiologic-mri-assessment-119971https://curecurrent.com/trials/quantitative-electroencephalogram-qeeg-predictors-of-response-to-psychotherapy-versus-antidepressant-treatment-in-depres-119972https://curecurrent.com/trials/relative-bioavailability-rba-study-of-ly03005-vs-pristiq-119973https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-sequential-parallel-study-of-cerc-301-in-the-adjunctive-treatment-of-subjec-119974https://curecurrent.com/trials/psilocybin-and-depression-119975https://curecurrent.com/trials/comparison-of-behavioral-activation-and-antidepressant-medication-in-the-treatment-of-adolescents-with-depression-119976https://curecurrent.com/trials/onabotulinumtoxina-as-treatment-for-major-depressive-disorder-in-adult-females-119977https://curecurrent.com/trials/treating-major-depressive-disorder-with-music-and-low-frequency-rhythmic-sensory-stimulation-119978https://curecurrent.com/trials/low-field-magnetic-stimulation-lfms-in-subjects-with-treatment-resistant-depression-trd-119979https://curecurrent.com/trials/effects-of-mindfulness-based-cognitive-therapy-on-emotional-processing-119980https://curecurrent.com/trials/transcranial-laser-therapy-for-major-depressive-disorder-119981https://curecurrent.com/trials/task-sharing-for-the-care-of-severe-mental-disorders-in-a-low-income-country-119982https://curecurrent.com/trials/safety-and-pharmacodynamic-study-of-abt-436-in-major-depressive-disorder-119983https://curecurrent.com/trials/paroxetine-bupropion-in-depression-with-suicide-attempt-or-thoughts-fmri-study-119984https://curecurrent.com/trials/effects-of-treatment-on-decision-making-in-major-depression-119985https://curecurrent.com/trials/a-study-of-the-effects-of-a-new-antidepressant-treatment-gsk561679-in-females-with-major-depressive-disorder-119986https://curecurrent.com/trials/clinical-study-to-test-a-new-drug-to-treat-major-depression-119987https://curecurrent.com/trials/slow-wave-sleep-deprivation-in-depression-119988https://curecurrent.com/trials/simplified-cognitive-behavioral-therapy-for-generalized-anxiety-disorder-and-depression-119989https://curecurrent.com/trials/european-drug-utilization-study-119990https://curecurrent.com/trials/study-of-functional-networks-in-resting-fmri-119991https://curecurrent.com/trials/a-randomised-double-blind-placebo-controlled-study-evaluating-the-efficacy-and-safety-of-orvepitant-in-subjects-with-maj-119992https://curecurrent.com/trials/does-enhanced-glutamate-transporter-function-produce-antidepressant-effects-in-people-with-major-depression-119993https://curecurrent.com/trials/multi-dimensional-diagnosis-individualized-therapy-and-management-technique-for-major-depressive-disorder-based-on-clini-119994https://curecurrent.com/trials/fish-oil-as-adjunct-treatment-for-major-depressive-disorder-119995https://curecurrent.com/trials/a-study-of-a-new-medicine-gw597599b-for-the-treatment-of-major-depressive-disorder-119996https://curecurrent.com/trials/mri-study-of-brain-activity-and-risk-for-depression-in-adolescents-119997https://curecurrent.com/trials/insulin-resistance-in-patients-with-major-depression-119998https://curecurrent.com/trials/does-dual-therapy-hasten-antidepressant-response-119999https://curecurrent.com/trials/an-efficacy-and-safety-study-of-escitalopram-long-term-treatment-in-major-depressive-disorder-with-associated-anxiety-sy-120000https://curecurrent.com/trials/a-study-of-intermittent-doses-of-cerc-301-in-mdd-120001https://curecurrent.com/trials/a-one-year-open-label-study-assessing-the-safety-and-tolerability-of-vilazodone-in-patients-with-major-depressive-disord-120002https://curecurrent.com/trials/effect-of-amygdala-neurofeedback-on-depressive-symptoms-and-processing-biases-120003https://curecurrent.com/trials/e-compared-ch-comparative-effectiveness-research-on-internet-based-depression-treatment-swiss-trial-120004https://curecurrent.com/trials/blended-depression-therapy-cognitive-behaviour-therapy-face-to-face-and-via-internet-120005https://curecurrent.com/trials/predictors-of-treatment-outcome-with-cognitive-behavioral-therapy-for-depression-120006